IN THE UN ITED STATES DISTRICT COURT (2024)

Agency decision

Ask Donna

What actually matters in this document.

Text

IN THE UN ITED STATES DISTRICT COURT

FOR THE MIDDLE DISTRICT OF NORTH CAROLINA

FEDERAL

TRADE

COMMISSION,

STATE OF CALIFORNIA, STATE OF

COLORADO, STATE OF ILLINOIS ,

STATE OF INDIANA, STATE OF

IOWA, STATE OF MINNESOTA, STATE

OF NEBRASKA, STATE OF OREGON,

STATE OF TENNESSEE , STATE OF

TEXAS , STATE OF WASHINGTON, and

STATE OF WISCONSIN,

Plaintiffs ,

1:22CV828

v.

SYNGENTA CROP PROTECTION AG ,

SYNGENTA CORPORATION, SYNGENTA

CROP

PROTECTION ,

LLC,

and

CORTEVA, INC . ,

Defendants.

MEMORANDUM OPINION AND ORDER

THOMAS D. SCHROEDER, District Judge.

In this action ,

states

allege

that

the Federal Trade Commission and a

two major manufacturers

dozen

of crop-protection

products have employed anticompetitive loyalty discount programs.

These programs

market

even

exclusivity

allegedly exclude

after

the

protections

generic competition

products '

have

patent

expired,

and

other

t hereby

from

the

federal

leading

to

supracompetitive prices for farmers.

Before the court are the

motions

Protection

of

Defendants

Syngenta

Crop

AG,

Syngenta

Corporation, Syngenta Crop Protection , LLC , and Corteva, Inc., to

dismiss all claims against them pursuant to Federal Rule of Civil

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 1 of 88

Procedure 12 (b) ( 6) .

opposition

133) .

(Doc.

(Docs. 94 , 99 . )

150),

Plaintiffs have responded in

and Defendants h ave replied

(Docs.

130,

The court held argument on the motions on December 1 , 2023.

(Doc. 157.)

For the reasons set forth below, the motions wi ll be

denied.

I .

BACKGROUND

A.

Factual Background

The

facts

"complaint")

out li ned in

Plaintiffs'

amended complaint

(the

(Doc. 1 49) , 1 which are taken as true for the purpose

of the present motion , show the following :

1.

Crop-Protection Product Industry

The Syngenta Group is a global company comprised of businesses

including

Defendants

Corporation ,

"Syngenta").

and

Syngenta

Syngenta

(Do C •

1 49

<J[

Crop

Crop

30 . )

Protection

Protection,

AG ,

Syngenta

LLC

(collectively

Syngenta Crop

Protection AG

oversees Syngenta ' s g lobal crop protection business.

( I d.

<J[

3 1.)

1

Limit ed portions of t he complaint and briefs remain under sea l.

{See

Doc. 148 {grant ing part ies ' mot ions to seal).)

Ci t ations are t o t he

unseal ed versions, except where t he court references sealed and redact ed

mat eri a l . While the court prel imi nar il y grant ed motions to seal portions

of the complaint in t his case , the court discloses here those portions

of the pleadings necessary for a full understanding of the allegations

and legal issues raised .

Courthouse News Serv. v . Schaefer, 2 F . 4th

318 , 327 {4 t h Cir. 2021) {"[A]ccess to [allegations in ] complaints . . .

is crucial to 'not only t he public's int erest in monitoring the

functioning of the courts but also t he integrity of the judiciary.'"

(quoting Doe v . Pub . Citizen , 749 F . 3d 246, 266 (4th Cir . 2014)); Doe,

749 F . 3d at 271 {"When parti es call on the courts, they must accept the

openness that goes wit h subsidized dispute reso l ution by publ ic {and

publicly accountable) offici als . " (internal quotation marks omitted)) .

2

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 2 of 88

Syngenta Corporation is a

corporate affiliate of Syngenta Crop

Protection AG and is the top- level Syngenta business incorporated

in the United States .

(Id.

<JI

Syngenta Crop Protection , LLC

32.)

operates Syngenta's U.S. crop-protection manufacturing, which is

the

second

largest

by

revenue

among

manufacturers in the United States.

crop-protection

(Id.

<Jl<Jl

allegedly operates as a single enterprise.

Corteva,

Inc.

33,

(Id .

48.)

<JI

product

Syngenta

35.)

("Corteva") was established to operate as an

independent agriscience business through the merger of E . I .

Pont de Nemours and Dow Chemical Company.

is the

(Id.

<JI

38.) 2

Corteva

third largest by revenue among crop-protection product

manufacturers in the United States.

(Id .

<JI

48.)

Defendants manufacture crop-protection products referred to by Plaintiffs as "pesticides" -

commonly

to control diseases,

weeds, insects , or other unwanted organisms that harm crops .

39,

40.)

fungicides.

(Id .

<j[<_j[

37,

<JI

include herbicides,

42.)

Every crop-protection product contains

sell

Ais

in

technical-grade

form,

(Id .

<JI

insecticides ,

(Id.

These

at least one active ingredient ("AI").

may

du

43 . )

which

and

Manufacturers

requires

further

processing before being sold in finished form, which is ready for

use by farmers .

(Id.

<JI

44.)

Ais are distinguished by the pests

2

To the extent the complaint includes allegations involving Corteva's

predecessor corporations, the court will simply refer to all such

entities as "Corteva.,,

3

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 3 of 88

they target, the effectiveness at controlling the target pest, and

t he crops upon which t he AI is used and registered for use, among

(Id.

other characteristics.

<JI

45.)

The AI's "mode of action" is

the chemical and biological manner in which the crop-protection

(Id .

product kills or controls the target pest.

46 . )

<JI

Farmers'

preferences for one AI over another may depend on variati ons in

t he mode of action.

Developers

mechanisms .

of

(Id.)

new

Ais

obtain

exclusive

use

through

two

First, under the Federal Insecticide, Fungicide, and

Rodenticide Act ("FIFRA"), 7 U.S.C. § 136 et seq., a developer of

crop-protection products must submit environmental impact data to

the

U.S .

Environmental

Protection

distribution in the United States.

Agency

prior

Upon approval,

to

sale

or

the developer

obtains 10-year exclusive protection from others citing t he data

the developer used to support its FIFRA submission.

52 .)

Second, under patent law,

patent

protection.

(Id .

<JI

(Id.

<j[<j[

51,

a developer can obtain 20-year

The

51.)

timing

of

the

FIFRA

application can effectively extend t he exclusive- use period beyond

the date the patent expires.

(Id.

<J[

52 . )

When both exclusive-

use protections expire, however, a generic manufacturer may enter

the market.

(Id.

<JI

54.)

Manufacturers of crop-protection products traditiona lly sell

to distributors,

who then sell to retailers,

farmers.

<JI

(Id.

55. )

Approximately

90%

who then sell to

of

crop-protection

4

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 4 of 88

products reach farmers through this traditional supply chain, and

about 90% of the traditional supply chain is managed by seven

In other words ,

distributors .

account

for

approximately 80%

products in the United States.

of all

(Id.)

these seven distributors

sales of crop-protection

This traditional channel of

distribution is allegedly the most efficient because it provides

access to retail and logistics networks and economies of scale ,

among other factors.

2.

(Id .

<JI

56 . )

Defendants ' Loyalty Programs

Plaintiffs allege that Defendants operate loyalty programs

intended to limit the distribution of competing generic products.

(Id.

<.II

59.)

Under these programs, Defendants offer "substantial"

payments as an end-of- year lump sum to distributors - allegedly up

to millions of dollars - conditioned on the distributors limiting

their purchases

of generic crop- protection products containing

specified post-patent Ais.

(Id.

the

expressed

loyalty

payment

is

<JI

60.)

The threshold to receive

as

a

percentage

of

the

distributors' total purchases of the AI , and the permissible amount

of generic AI a distributor may sell is referred to as "open space"

or "head space."

(Id . <JI 61.)

Typically, a distributor must source

less than 15 % of its total purchase of a certain AI from generic

manufacturers to qualify to receive the loyalty payment.

Syngenta implements its loyalty program,

through

written

marketing

agreements

with

(Id. )

known as "Key AI,"

distributors .

5

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 5 of 88

(Id.

<JI

66. )

Loyalty performance is calculated by dividing the amount

of qua l ifying AI purchased or so l d by the distributor in the year

by the

to t al of the AI purchased or sold by the distributor ,

including generics.

(Id.

<JI

68 . )

If the distributor ' s percentage

is above the threshold for the specific AI, it will reap a "special

marketing bonus . "

(Id.

<JI

69.)

If not, the distributor will lose

the entire loyal ty payment.

change the Ai s

Year-to-year,

Syngenta can

included in distributor marketing agreements as

well as the associated share thresholds and calculation methods .

(Id.

<JI

70.)

A similar program is offered for retailers as well ,

in which multiple top retailers nationally have participated .

':![<JI

71 , 72; Doc. 81

<JI

Under Corteva' s

(Id.

82 . )

program -

the Crops ,

Industrial Vegetation Management

( "CRPIVM")

Range

&

Pasture and

Loyalty Program,

a

distributor generally receives an annual payment for sourcing a

certain percentage of its purchases of an AI from Corteva.

149 ':![':I[ 75 , 77 . )

(Doc.

The percentage that Corteva pays varies but could

run as high as 11%.

(Id.

<JI

77.)

Corteva offers a second, higher

payment when a distributor reaches a high er threshold for the AI .

(Id.

':I[

75 . )

Moreover, the CRPIVM usually links together multiple

active ingredients within each offer, thus requiring a distributor

to hit the loyalty threshold for every AI in the offer to receive

the payment for any one AI .

(Doc . 81 <j[ 75 . )

Additionally, Corteva

typically permits a portion of any payment to be deferred into

6

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 6 of 88

subsequent

years,

which

would

otherwise

be

forfeited

if

the

distributor missed the l oyal ty t hresho l d for any AI in t he offer.

(Id.

<JI

Further ,

78.)

Cort eva conditi ons its Corporate Offer -

another annual payment offer that covers a broader range of Corteva

products -

on meeting the CRPIVM figure .

distributor fails to qualify,

(Id .

<JI

If a

79 . )

it could forfeit certain loyalty-

dependent payments under the Corporate Offer.

(Id. )

" [S]ubstantially all l eading distributorsn enter into l oyal ty

program agreements,

and Defendants promote broad participation

allegedly to assure distributors that others are not partnering

with generic manufacturers to undercut prices .

(Doc . 149

<JI

84.)

Moreover, the structure of the program is designed to make it less

likely that distributors will lower prices in anticipation of a

future loyalty payment because of its complexity, uncertainty, and

timing.

(Id .

<JI

85.)

Defendants "regularlyn audit distributors ,

which has a llegedl y l ed to withhe l d l oyal ty payments.

<JI

87 . )

(Doc. 8 1

Defendants also "rarelyn grant exceptions for missing the

threshold without good cause .

(Doc .

149

<JI

87 . )

Additionally ,

they have allegedly retaliated against distributors who fail to

reach the loyalty thresholds by canceling distribution contracts,

delaying

access

to

new

products ,

and

al l ocation during a supply shortage.

(Id.

withholding

<JI

product

88.)

7

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 7 of 88

Plaintiffs focus on the fo l lowing Ai s:

Syngenta AI

Azoxystrobin

(fungicide)

Mesotrione

(herbicide)

Metolachlor 3

(herbicide)

Corteva AI

Rimsulfuron

(herbicide)

Oxamyl

(insecticide/

nematicide)

Acetochlor 4

(herbicide)

Current

Loyalty

Threshold

Date Added

to Loyalty

Program

Patent

Expiration

FIFRA

Expiration

92%

20 13-14

2014

2010

92%

2014 -1 5

2008

2014

2008

2010

Patent

Expiration

FIFRA

Expiration

Current

Loyalty

Threshold

Early

2000s

Date Added

to Loyalty

Program

85%

2017-18

2006

2007

90%

After 2017

Merger

1988

1987

95%

20 1 6- 17

2000

2007

90 %

(See id . 11 89-150 ; Doc . 81 11 89-150.)

Plaintiffs allege that

distributors of each of these Ais have strictly managed their

purchases and sales to ensure that they stay above the respective

threshold t o receive the payments.

Further ,

Plaintiffs

allege,

generic

manufacturers

attempted to enter the market for each AI -

have

with demand from

farmers - but have had little to no success because distributors

Syngenta produces "s-metolachlor," which was phased in by 2001 over

the original metolachlor. (Doc. 1 49 '][ 114.) However, Syngenta allegedly

includes sales of generic original metolachlor in the denominator of its

calculation of a distributor's loyalty figure.

(Id . 'l[ 115.)

3

4

Acetochlor is manufactured by a joint venture of Corteva and Bayer .

Corteva apparently treats the sale or purchase of

(Doc . 149 '][ 142 .)

Bayer acetochlor as it would a sale or purchase of Corteva acetochlor .

(Doc . 81 <JI 146 .)

8

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 8 of 88

would not purchase the generic.

As to azoxystrobin ,

two

generics have exited the market entirely, and one that attempted

to mix azoxystrobin was "hindered in its attempt to market" because

of the Key AI program.

two

generics

delayed

(Doc . 14 9

or

<J[ <J[

9 6- 9 7 . )

As to mesotrione,

terminated

entry,

and

a

third

that

developed a mixture product dropped it due to the Key AI program.

(Id.

<J[

As

105.)

to

metolach l or,

a

generic

manufacturer

had

considered bringing a mixture to market but chose not to do so

because of the Key AI program .

(Id .

<J[

120.)

As to rimsulfuron ,

at least one generic canceled or deferred entry plans ,

despite

apparent demand from farmers to bid on generics, because of the

CRPIVM program.

(Id.

<J[

As to oxamyl , Corteva's production

132.)

of oxamyl stopped for a span of roughly two years, generics entered

the

market

with

"plummeted"

upon

"relative[]

Corteva' s

success[],"

re - entry

loyal ty program appl ied to oxamyl.

acetochlor,

but

into

(Id.

the

<J[<J[

generic

market

1 36-38 .)

sales

with

the

And as to

the CRPIVM program has allegedly deterred generics

from the market altogether, even t hough one generic firm has had

success selling the AI overseas.

Plaintiffs

allege

that

the

(Id.

presence

of

<JI

149 . )

For each AI,

generics

has

imposed

downward pricing pressure.

The complaint further alleges t hat Syngenta supplies Corteva

with mesotrione and metolachlor .

(Id .

<J[<j{

109, 122 . )

Defendants

allegedly struck this agreement as an incentive to keep Corteva

9

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 9 of 88

from purchasing generics of these two Ais.

does not penalize distributors

Corteva products

<[<JI

containing

In exchange , Syngenta

in the Key AI program who buy

these

two

Syngenta

Ais .

(Doc .

81

109 , 122.)

3.

Alleged Market and Competitive Harm

Plaintiffs allege that Syngenta has had monopoly and market

power as to azoxystrobin,

mesotrione, and metolachlor ,

and that

Corteva has had monopol y and market power as to rimsulfuron and

oxamyl and market power as to acetochlor .

(Doc. 149 <JI<JI 151, 152 . )

Plaintiffs claim two relevant product markets :

(a) A relevant product market exists that is no broader

t han the active ingredient , consisting of ( 1) active

ingredient included as a component of an EPA-registered

finished crop-protection product for sale in the United

States, and (2) technical-grade or manufacturing-use

active ingredient to be formulated into an EPA­

registered finished crop- protection product for sale in

the United States; a nd

(b) A relevant product market(s) also exists that is no

broader than EPA-registered crop-protection products for

sale in the United States that contain the active

ingredient.

(Id.

<JI

155 . )

Syngenta' s market share for azoxystrobin, mesotrione,

a nd metolachlor exceeded 70% from at least 2017 through 2020.

<JI

1 61. )

(Id .

Corteva's market share for rimsulfuron and oxamyl also

e xceeded 70% for those same years ,

whi l e

its market share for

acetochlor exceeded 40% (with another roughly 50% attributabl e to

Bayer , its joint venture partner for t hat AI).

(Id .

<][<JI

162, 163.)

In all , Plaintiffs allege that Defendants have foreclosed generics

10

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 10 of 88

from "approximately 70% or more" of the market.

Each

AI

has

"particular

(Doc. 81

characteristics

differentiate it from other active ingredients . "

and

<JI

171.)

uses

that

(Doc. 149 <JI 157 . )

Azoxystrobin "can be used across all major row crops

[and]

has

growth-enhancing effects not proven in other active ingredients . "

Mesotrione has "superior efficacy and crop safety,

low use rate."

(Id . )

and

to

so

tends

and a

Metolachl or has "superior water solubility ,

perform better

in

dry

conditions [ ,

and

it]

outperforms other active ingredients in warmer conditions, is more

' crop friendly , ' and can be used on a broader spectrum of crops."

(Id. )

Rimsulfuron "can be used on a

broader range of crops,

controls a wider spectrum of weeds , can be used on both pre- and

post-emergence,

and has

more

application methods,

no dormancy

restrictions , and a lower use rate."

(Id . )

directly onto crops ,

similar insecticide active

whereas other,

Oxamyl can be "sprayed

ingredients must be applied at the root level or mixed into the

soil[, and] is also safer for crops and better for soil health[.]"

(Id.)

Acetochlor "tends to perform better in wetter and cooler

conditions,

[and] tends to have better weed control early in the

growing season and is more effective against certain weed species . "

(Id.)

Plaintiffs

substitutes

allege

to

supracompetitive

that

prevent

prices

of

other

Ais

Defendants

their

are

not

from

c l ose

enough

maintaining

crop-protection

products

11

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 11 of 88

containing these six Ais .

(Id.

<J[

158.)

Moreover ,

substantial

barriers exist to enter the market for these Ais no twiths tanding

(Id.

the loyal t y programs.

regulatory,

from the

160.)

<J[

and legal barriers

EPA,

These capital ,

include

technical ,

"obtaining registration

developing manufacturing processes

and sourcing

[the] active ingredient , and paying data compensation costs to the

initial active ingredient registrant ."

(Id.)

The loyalty programs

impose a substantial barrier by limiting generic manufacturers '

access to the traditional distribution channel .

Plaintiffs

contend that

competitive harms .

First ,

the

loyalty programs

t he programs

cause

"forclos [e]

anti-

actual or

potential competitors from access to distribution services ," or to

" efficient

distribution

distribution channel).

services"

(Id.

<J[<_J[

(i.e .,

1 69 , 170.)

the

traditional

Although t he programs

are nominally voluntary , Plaintiffs allege that the mere prospect

of

rece i ving

a

payment

is

sufficient

incentive

to

induce

distribu tors to participate and to limit or forego purchases from

generic

compe t i t ors .

(Id.

<_J[

173 .)

Allegedly,

one

generic

manufacturer represented that " this dynamic is so we ll establ ished

in

the

industry

that

it

is

futile

to

even

approach

distributor that is subject to loyalty requirements."

(I d .

a

large

<J[

178.)

Absent t he loyal ty programs, Pl aintiffs al l ege , sal es of generics

would be significantly higher and would exceed t he open space

presently allowed for each AI, thus decreasing prices overall for

12

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 12 of 88

farmers.

(Id.<[ 180.)

Second,

programs

and relatedly,

have

prevented,

Plaintiffs charge that the loyalty

delayed,

and

expansion by generic manufacturers into,

diminished

entry

as well as caused the

exit from, the market for products containing the Ais.

see

also,

id .

e .g. ,

<[<[

96-97

and

(demonstrating

(Id .

that

<_j[

182;

generic

manufacturer of azoxystrobin mixture was "hindered in its attempt

to

market";

id .

<[

132

(alleging

t hat

at

leas t

one

generic

manufacturer of rimsulfuron canceled or deferred entry plans,

despite apparent demand from farmers to bid on generics, because

of the CRPIVM program).)

Third, t hese programs have reduced the

ability and incentive for generic manufacturers to innovate cropprotection products containing the Ais.

the

programs

have

resulted

for

in

(Id. <[ 186.)

supracompetitive

retailers

and farmers

products

<[ 190.)

Plaintiffs point to Defendants'

Finally ,

prices

containing the Ais.

for

(Id.

internal studies that

allegedly demonstrate that the loyalty programs have curtailed

generic entry and sustained higher prices t han would otherwise

prevail.

B.

(Id.

<JI<[

195-99.)

Proc edural History

On September 29, 2022, Plaintiffs filed t his action seeking

declaratory,

injunctive,

penalties .

(Doc . 1 . )

complaint,

equitable

monetary

relief,

and

civil

Defendants moved to dismiss the original

after which Plaintiffs

filed an amended complaint.

13

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 13 of 88

(Doc. 79 ; Doc . 149 (lesser-redacted complaint).)

Now before the

court are Defendants' motions to dismiss the amended comp l aint .

(Docs . 94 , 99.)

respective

Following this court's order granting the parties '

motions

to

seal

(Doc.

148) ,

the

operative

public

complaint i s at docket entry 1 49. 5

Plaintiffs allege sixteen counts under state and federal law.

Under

federal

l aw,

Plaintiff Federal Trade

Commission

("FTC" )

alleges violations of Section 5 of the FTC Act , 15 U.S.C. § 45(a),

and all Plaintiffs allege violations of Section 3 of the Clayton

Act , 15 U. S . C. § 14 , and Sections 1 and 2 of the Sherman Act , 15

U. S . C. §§ 1, 2 .

under

state

Colorado ,

(Doc . 149 i~ 203- 10.)

law and

Illinois ,

are

The remaining c l aims arise

raised by the

Indiana ,

Iowa ,

states

Minnesota ,

Te n nessee, Texas , Washington , and Wisconsin . 6

of California ,

Nebraska ,

Oregon ,

(Id . ii 2 12-76 . )

5

Separ ate simi lar act i ons brought by farmer s have been consolidated by

the Uni ted St ates Judi cial Panel on Multidis t r i c t Li tigati on and

transferred to thi s court for pretrial p r oceedi ngs .

(See Doc . 78 i n

1 : 23-md-3062 (amended consoli dat ed complai n t ) ; I n r e Crop Pr o t ection

Pr ods . Loyalt y Pr ogram Antitrust Liti g . , 655 F . Supp . 3d 1380 (J.P . M. L .

2023) .

6

Specifical ly, t he s t ate law clai ms a ri se under Californi a's Cartwri gh t

Act , Califo r nia Business and Pr o f ess i ons Code § 16700 e t seq . , and

California' s Unfair Compet ition Law, California Business and Prof essions

Code§ 17200 e t seq . ; t he Colorado Ant itru s t Act , C . R . S. § 6-4-104 and

C.R.S. § 6- 4 - 105 ; Secti on 7 of t he Illinoi s Ant i t rus t Act , 740 ILCS 10/1

e t seq. ; t he Indi ana Decepti ve Consumer Sales Act , Ind. Code§ 24 - 5- 0.5 1 e t seq. and t he Indiana Ant itrust Act , Ind. Code§ 24-1-2-1; t he Iowa

Compet i t ion Law, I owa Code Chapt er 553, and t he Iowa Consumer Fraud Act ,

Iowa Code § 714.16 ; the Minnesota Ant itrust Law of 1971, Minnesota

St atut es Sect ions 3250.49- .66; t he Nebraska Consumer Prot ect ion Act,

Neb. Rev. St a t . §§ 59-1 602 et seq . , and Neb . Rev . St at . § 84 - 21 2; t he

Oregon Antit rust Law , Oregon Revised Stat utes 646 . 705 to 646 . 836 ; the

14

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 14 of 88

Following oral argument on the motions to dismiss , they are

ready for reso l ution.

II .

ANALYSIS

A.

Legal Background

1.

Mo tion t o Dismiss Standar d

A Rule 12 (b) ( 6)

sufficiency

of

a

motion to dismiss is meant to "test []

complaint"

and

not

to

" resolve

the

contests

surrounding the facts, the merits of a claim, or the app l icabi l ity

of defenses . "

Republican Party of N. C . v . Martin ,

952 (4th Cir . 1992).

980 F . 2d 943,

To survive such a motion , " a complaint must

contain sufficient factual matter , accepted as true , to ' state a

claim to relief that is plausible on its face . ' "

Iqbal ,

556

U.S.

662 ,

678

(2009)

Twombly, 550 U.S . 544 , 570 (2007 )).

Ashcroft v .

(quoting Bell Atl.

Corp .

v.

In considering a Rule 12 (b) (6)

motion , a court "must accept as true all of the fact ual allegations

contained in the complaint , " Erickson v . Pardus, 551 U.S. 89 ,

(2007)

94

(per curiam) , and all reasonable inferences must be drawn

in the non- moving part y ' s favor , I b arra v . Uni t ed States , 120 F . 3d

472 , 474 (4th Cir. 1 997) .

Ru l e 12(b) (6) must be read in l ight of

Ru le 8' s

standard that a

complaint con tain "a short and plain

statemen t

of the claim showi ng that the pleader is entitled to

Tennessee Trade Practices Act, Tenn . Code Ann. §§ 47 - 25 - 101 et seq . ;

Sections 15 . 20(a) and 15 . 20(b) of the Texas Business and Commerce Code

and Section 402 . 006 of the Texas Government Code; the Washington Consumer

Protection Act , RCW 19 . 86 . 030 et seq . ; and the Wisconsin Antit rust Act ,

Wis . Stat . Ch . § 133 . 03 et seq .

15

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 15 of 88

relief."

Fed . R. Civ. P. 8 (a) (2).

2.

Federal Antitrust Statutes

Plaintiffs allege violations of the Sherman Act (sections 1

and 2)

and Clayton Act

(section 3) ,

and Pl aintiff FTC alleges

violations

of

the

Federal

Trade

Commission

Section

of

the

Sherman

Act

prohibits

1

Act

(section

" [e]very

5).

contract ,

combination in the form of trust or otherwise , or conspiracy, in

restraint of trade or commerce among t he several States , or with

foreign

nations . "

15

u. s .c.

§

1.

Section

2

prohibits

" monopoliz[ing] , or attempt [ing] to monopolize , or combin [ ing] or

conspir[ing] with any other person or persons, to monopolize any

part of the trade or commerce among the several States . "

§

2.

15 U. S.C .

A violation of Section 2 consists of two elements :

(1)

possession of monopoly power and (2) "maintenance of that power as

distinguished from growth or development as a consequence of a

superior product, business acumen, or historic acc i dent."

Kodak Co .

(1992).

v.

Image Technical

Servs .,

Inc.,

504 U. S .

Eastman

451 ,

48 1

Monopoly power is defined as the ability "to control

prices or excl ude competition . "

United States v . Grinne l l Corp.,

384 U. S . 563 ( 1 966 ) (internal quotation marks omitted) .

Al though

evidence of such abi l ity is " only rare l y available , " courts turn

to circumstan tia l

evidence -

such as a company's share of the

market - to determine whether monopoly power exists .

United States

v . Dentsply Int ' l , Inc ., 399 F . 3d 181, 187 (3d Cir . 2005)

(quoting

16

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 16 of 88

United States v.

2001)).

Microsoft Corp.,

253 F.3d 3 4,

51

(D.C.

Cir.

Maintenance of that power requires some illegal conduct

that forecloses competition,

destroys a competitor.

gains a

competitive advantage,

or

Eastman Kodak, 504 U.S . at 482-83.

Section 3 of the Clayton Act makes it unlawful for

any person engaged in commerce .

. to lease or make a

sale or contract for sale of goods

for use,

consumption, or resale within the United States.

. or

fix a price charged therefor , or discount from, or rebate

u pon , such price, on the condition, agreement, or

understanding that the lessee or purchaser thereof shall

not us e or deal in the goods . . . of a competitor or

competitors of the lessor or seller, where the effect of

such lease , sale , or contract for sale or such condition,

agreement, or understanding may be to substantially

lessen competition or tend to create a monopoly in any

line of commerce.

15 u.s.c. § 14.

Section 5 of the FTC Act makes illegal "[u ] nfair methods of

competition in or affecting commerce , and unfair or deceptive acts

or practices in or affecting commerce . "

15 U. S.C .

The act, while not solely focused on antitrust ,

linked to the antitrust laws ."

Ralston Purina Co.,

§

45(a) (1).

is "nonetheless

Chuck's Feed & Seed Co., Inc. v.

810 F .2d 1289,

1293

(4th Cir .

1989).

The

Supreme Court has stated that the act was "designed to supplement

and bolster the Sherman Act and the Clayton Act,

[]

to stop in

their incipiency acts and practices which, when full blown, would

violate those Acts."

Fed. Trade Comm'n v. Motion Picture Advert.

Serv. Co., 344 U.S . 392, 394-95 (1953 ) (internal citation omitted).

17

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 17 of 88

The

act

"functions

as

a

kind of penumbra

around the

federal

antitrust statutes," Chuck' s Feed, 810 F.2d at 1292-93, such that

any practice that violates the Sherman Act or the Clayton Act also

violates the FTC Act.

See Fed. Trade Comm'n v.

Dentists, 476 U. S. 447 , 454 (1986)

Ind.

Fed'n of

("The standard of 'unfairness'

under the FTC Act is, by necessity, an elusive one , encompassing

no t

only practices that violate the Sherman Act and the other

antitrust

laws,

[]

but

also

practices

t hat

t he

Commission

determines are against public policy for other reasons." (internal

citations omitted)).

The extent to which these four provisions

impose varying requirements on a plaintiff is discussed in more

detail below.

3.

Exclusive Dealing

Plaintiffs allege that Defendants'

loyal ty rebate programs

are illegal exclusive dealing arrangements.

An exclusive dealing

arrangement is one in which a buyer agrees to purchase certain

goods or services only from a particular seller for a certain

period of time.

Phillip E. Areeda & Herbert Hovenkamp, Antitrust

Law~ 1800a (4th & 5th ed. 2023).

Neither absolute exclusivity

nor an express agreement is necessary for an exclusive dealing

arrangement to violate antitrust laws .

ZF Meritor, LLC v . Eaton

Corp., 696 F.3d 254, 270, 282 (3d Cir. 2012); Tampa Elec. Co. v.

Nashville Coal Co. , 365 U.S . 320 , 328

f oreclosed

by

the

contract

must

be

(1961)

found

("[T]he competition

to

constitute

18

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 18 of 88

a

substantial

share

of the

relevant market."

(emphasis

added)) .

Although not "per se " i llegal , exclusive dealing arrangements may

give rise to cognizable claims under all four statutory provisions

alleged here.

See, e .g., Grinnell Corp., 384 U.S. at 576 (Sherman

Act § 2); ZF Meritor,

696 F.3d at 281

(Sherman Act §§ 1 and 2,

Clayton Act§ 3) ; LePage's Inc . v. 3M, 324 F . 3d 141, 157 & n . 10

(3d Cir . 2003)

(same); Allied Orthopedic Appliances Inc. v. Tyco

Health Care Grp. LP, 592 F . 3d 991 ,

Act

§

1); McWane,

996 (9th Cir. 2010 )

783 F . 3d 814 ,

827

Exc l usive contracts serve many pro-competitive purposes.

ZF

(11 th Cir. 2015)

Meritor ,

Inc. v. Fed . Trade Comm'n,

(Sherman

(FTC Act

§

696 F . 3d at 270.

5).

On the demand side ,

they can assure

supply, protect against rises in price, enable long-term planning

based on known costs , and reduce the expense and risk of storing

goods that have fluctuating demand.

States, 337 U.S. 293, 306

substantially

reduce

(1949) .

selling

Standard Oil Co . v. United

On the supply side, they can

expenses ,

protect

against

price

fluctuations , justify and enable capital expenditu res, and shield

against counterattacks by competitors.

"virtually

every

contract

to

buy

Id . at 306- 07.

' forecloses'

or

Indeed,

'excludes'

alternative sellers from some portion of the market, namely the

portion consisting of what was bought."

Grinnell Corp . ,

(emphasis

724 F . 2d 227,

removed) .

Barry Wright Corp. v. ITT

236

(1st Cir.

1983)

(Breyer ,

Accordingly,

whether a

contract

rises

19

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 19 of 88

J .)

to

illegal

exclusivity,

"rather

than

merely

a

competition, can be difficult to discern[.]"

F.3d at 58.

antitrust court

in

as

Microsoft Corp., 253

acts ,

general rule

which

reduce

competitive acts , which increase it. "

(e . g.,

vigorous

are myriad," posing a challenge for an

"stating a

exclusionary

While

of

"[T]he means of illicit exclusion , like the means of

legitimate competition,

between

form

exclusive dealing is

alleged here,

distributor),

it

has

a

the

for distinguishing

social

welfare,

Id.

formally a

vertical

restraint

restraint

between manufacturer

potential

to

have

adverse

on horizontal

competition.

Jefferson Par.

Dist.

v.

U. S .

(1984)

2

concurring).

Hyde,

466

2,

45

and

economic

consequences

No .

and

Hosp.

(O'Connor,

J .,

More specifically, an exclusive dealing arrangement

runs afoul of the antitrust laws when it unreasonably deprives

other suppliers of a market for t heir goods or allows one buyer of

goods unreasonably to deprive other buyers of a needed source of

supply.

exclusive

Id.

The potential collateral consequences of illegal

dealing

include

higher

prices,

reduced quality, or slower innovation.

restricted

output,

McWane, Inc . , 783 F . 3d at

827.

B.

Defendants ' Grounds for Motion to Dismiss

Defendants

complaint : first,

argue

two

primary

grounds

to

dismiss

the

t hey contend that Plaintiffs fail to allege a

relevant product market; and second, they argue that Plaintiffs

20

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 20 of 88

fail

to

allege

anticompetitive

conduct

and

injury .

Syngenta

further argues that the claims against Syngenta Crop Protection AG

and Syngenta Corporation should be dismissed .

Corteva argues that

the FTC Act violates Article II of the U.S .

Constitution,

requiring dismissal of the complaint.

thus

And finally , all Defendants

argue that the state law claims should be dismissed on a range of

grounds.

The court turns first to the thresho ld question of whether

Plaintiffs allege a relevant product market.

1.

Relevant Product Market

Defendants contend that the complaint is defective because it

fails to allege a cognizable product market .

(Doc. 95 at 17; Doc .

100

is

at

37.)

A

relevant

product

market

defined

by

"the

reasonable interchangeability of use or the cross-elasticity of

demand between the product itself and substitutes for it."

Shoe Co. v . United States, 370 U.S. 294, 325 (1962).

Brown

Courts begin

with a preliminary inquiry into market definition because it serves

as the frame through which the court analyzes monopoly power and

substantial market foreclosure .

E.I. Du Pont De Nemours & Co. v .

Kolon, 637 F . 3d 435, 441 (4th Cir . 2011); Ind . Fed'n of Dentists,

4 7 6 U.S .

at

4 60

(" [T] he purpose of the

inquiries

into market

definition and market power is to determine whether an arrangement

has the potential for genuine adverse effec t s

on competition . "

(emphasis in original)).

21

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 21 of 88

Plaintiffs allege two product markets in the United States.

One is the AI itsel f ,

(Doc . 149

form .

<J[

in both its finished and technical -grade

155 . )

The other is crop-protection products

that contain the active ingredient.

Defendants do not

contest the markets ' geographical scope or that Plaintiffs allege

more than one market .

Corteva argues that Plaintiffs ' market definitions are only

two sentences that vaguely describe general characteristi cs of the

Ais

that

amount

products. "

to

"alleged advantages

( Doc . 9 5 at 19 . )

they

have

over

other

In Corteva ' s view, Plaintiffs have

an obligation to do more - namely, to expl ain why products without

those characteristics are not reasonably interchangeable .

(Id . at

18 (cit i ng Bayer Schering Pharm AG v. Sandoz , Inc. , 813 F. Supp.

2d 569 ,

575

(S.D . N. Y. 20 11) ; Todd v . Exxon Corp ., 275 F . 3d 191,

200 (2d . Cir . 2001)) . )

l abe l

registrations

In support , Corteva points to several EPA

outside

of

the

record that ,

per Corteva,

demonstrate that the alleged produ ct markets are both too narrow

and too broad.

This follows , according to Corteva , because these

EPA l abel

registrations show that the EPA has registered crop­

pro tection

produ cts

that

(1)

contain

Ais

alleged markets but have different uses,

outside of Pl aintiffs '

(Id . a t 19- 20 . )

within

and

(2)

Plaintiffs'

are products

alleged markets but share similar uses.

Syngenta argues that Plaintiffs ' market definition

is unreasonably narrow because each market is only a single AI.

22

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 22 of 88

(Doc.

100

at

38-40 . )

In

support ,

Syngenta

points

to

other

antitrust proceedings outside of t he record where t he FTC and the

U.S. Department of Justice have alleged broader crop-protection

product markets with multiple Ais.

(Id. at 41-42 . )

For example,

Syngenta cites United States v . Bayer AG, 83 Fed. Reg. 27652 , 27653

(DOJ

June

herbicides '

2018) ,

13,

as

"analyzing

alleged

' fou ndational

and ' nematicidal seed treatment' markets ,ll and Ciba-

Geigy Ltd ., 62 Fed. Reg. 409, 4 12 (FTC Jan. 3 , 1 997), as "analyzing

alleged

'corn herbicides

market -

includ ing metolachlor -

emergent control

for

pre-emergent control

of grasses'

and ' corn herbicides for post-

of broadleaf weeds'

market ."

Syngenta

contends that FTC ' s effort to allege narrower product markets here

is not based on "different facts ,

philosophy of the

FTC ' s

but instead on the evolving

Chair," and demons trates that "FTC is

attempting to gerrymander its way to an antitrust victory ."

(Id.

at 42 (internal quotation marks omitted).)

Plaintiffs respond that their product markets are supported

by

ample

factual

allegations.

(Doc.

150

at

52 . )

Namely ,

Plaintiffs point to the conduct of Defendants, who des ign the ir

loyal ty programs

around each

Plaintiffs

"characteristics

allege

individual AI .

and usesll

Further,

and " industry or

public recognition" for each AI:

Azoxystrobin has " growth-enhancing effects not proven in

other active i ngredients."

Mesotrione has "superior

efficacy and crop safety" "[c ]ompared to other, similar

23

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 23 of 88

herbicide

active

ingredients."

Metolachlor "has

superior water solubility," and "outperforms other

active ingredients" in warmer and drier conditions .

Rimsulfuron "has more application methods, no dormancy

restrictions , and a lower use rate " than similar

chemicals.

Oxamyl , unlike "similar insecticide active

ingredients, " "can be sprayed directly onto crops." And

acetochlor " tends to perform better" than similar

herbicides "in wetter and cooler conditions," and has

" better weed control early in the growing season."

(Id.

(quoting

Doc.

149

1

157)

(internal

citations

omitted).)

Plaintiffs also allege that each AI is distinguishable enough that

farmers "may prefer it over others."

1 46) .)

(Id. at 54 (citing Doc. 149

Finally, Plaintiffs contest that t he court should take

judicial notice of the EPA label registrations and prior FTC and

DOJ antitrust proceedings at this stage .

A

relevant

product

market

interchangeable products.

products

is

include

all

reasonably

United States v . E . I . du Pont de Nemours

& Co ., 351 U.S . 377, 404 (1956).

of

must

(Doc. 150 at 58-59.)

generally

The reasonable interchangeability

determined

according

to

the

cross-

elasticity of demand for the product and its alternatives .

It's

My Party, Inc. v. Live Nation, Inc., 811 F.3d 676, 683 (4 th Cir.

2016).

In other words,

courts look to the degree to which a

defendant would sacrifice sales to alternative products by raising

t he price of its goods.

Eastman Kodak ,

504 U.S. at 469.

therefore more than simply technical interchangeability .

It is

Rothery

Storage & Van Co. v. Atlas Van Lines, Inc., 792 F .2d 210, 218 n . 4

(D. C. Cir. 198 6)

(discussing functional subs titutability as one

24

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 24 of 88

factor among many as it relates to "the economic criteria that

make one market distinct from another").

Market definition is a question of fact .

442

(collecting cases).

fact-intensive

inquiry,

dismiss for failure

Kolon , 637 F.3d at

"Because market definition is a deeply

courts

hesitate

to plead a

to

grant

motions

to

relevant product market."

(quoting Todd, 275 F .3d at 199-200).

Id.

Nevertheless, there is "no

absolute rule against the dismissal of antitrust claims for failure

to allege a relevant product market . "

at 199-200).

Id . (quoting Todd, 275 F.3d

"No party can expect to gerrymander its way to an

antitrust victory without due regard for market real ities."

My Party, Inc ., 811 F . 3d at 683 .

pleadings

is

appropriate

It's

"Cases in which dismissal on the

frequently

involve either

(1)

failed

attempts to limit a product market to a single brand, franchise,

institution ,

or comparable entity that competes with potential

substitutes or (2) fai l ure even to attempt a plausible explanation

as to why a market should be limited in a particular way."

Kolon,

637 F . 3d at 442 (quoting Todd, 275 F.3d at 199-200).

Under this fact-intensive inquiry, the scope of the relevant

product market differs on a case-by-case basis .

For example, in

Eastman Kodak , 504 U.S . at 481-82, the Supreme Court held that a

properly constituted market may be comprised of a single product.

In the pharmaceutical context,

lower courts have ruled that a

brand-name drug and its generic analogs can comprise a relevant

25

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 25 of 88

product market .

In re Zetia (Ezetimibe) Antitrust Litig. , MDL No.

2: 1 8-md-2836 , 202 1 WL 66897 1 8 , at *1 8-20 (E . D. Va . Nov . 1, 202 1 ),

adopted in full by 587 F . Supp . 3d 356

(E.D. Va . 2022);

In re

Nexium (Esomeprazole) Antitrust Litig., 968 F . Supp. 2d 367, 388

(D. Mass. 2013) ; In re Cardizem CD Antitrust Litig. , 1 05 F. Supp.

2d 61 8 , 680- 81 (E . D. Mich . 2000)

(accepting plaintiffs ' contention

on motion to dismiss that branded and generic versions of heart

medication constitute a single market), aff ' d, 332 F.3d 896 (6th

Cir. 2003) .

Whether a market is plausible when comprised of a

single product - or many products - " can be determined only after

a

factua l

inquiry

consumers."

into

the

'commercial

realities '

faced

by

Eastman Kodak , 504 U. S. at 482 (quoting Grinnell Corp ,

384 U.S. at 572).

Courts employ a variety of methods to de t ermine if a product

market is properly constituted.

consider

( 1) the Defendants '

Plaintiffs urge the court to

own conduct;

(2)

the "hypothetical

monopolist test"; and (3) the factors set out in Brown Shoe , 370

U. S.

294 .

(Doc .

150

at

49- 52 . )

Courts

Plaintiffs '

first

proposed methodology -

generally

the

consider

Defendants '

own

conduct and recognition of the market - under the assumption that

" economic actors usually have accurate perceptions of economic

rea l ities."

Todd,

275 F. 3d at 205

(collecting cases)

(quoting

Rothery Storage, 792 F . 2d at 218 n . 4) ; Kolon , 637 F . 3d at 442 - 43

(considering

the

"area

within

which

the

defendant

and

26

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 26 of 88

its

competitors view themse lves as competing").

Plaintiffs' second proposed methodology is the hypothetical

monopolist test ("HMT") .

The HMT is an aid in determining if the

relevant product is properly constituted.

The court begins by

hypothesizing that every good as alleged in the product market is

under the control of a hypothetical monopolist.

Am.

United States v .

Express Co., 838 F.3d 179, 198-99 (2d. Cir. 2016).

Under such

conditions, if the hypothetical monopolist could profitably impose

a

small

but

significant

and

nontransitory

increase

("SSNIP"), then the product market is properly defined.

contrast,

the

product

market

is

improperly

defined

in

price

Id .

By

when

the

hypothetical monopolist imposes the SSNIP unprofitably because the

alleged market does not include reasonably interchangeable goods

-

i.e., goods that consumers will shift demand toward in light of

the SSNIP.

test,

Id.

While the Fourth Circuit has yet to endorse this

other circuits have at least acknowledged it or outright

embraced it as a viable methodology in the context of defining

markets.

See, e.g., Fed. Trade Comm'n v. Penn State Hershey Med.

Ctr . , 838 F . 3d 327, 339-41 (3d Cir. 2016)

(adopting HMT as proper

test to define market); Fed . Trade Comm' n v . Sanford Health, 926

F.3d 959 ,

964

(8th Cir. 2019)

(holding not clear error to define

relevant market with HMT); Fed. Trade Comm'n v. Advocate Health

Care Network, 841 F .3d 460, 473 (7th Cir. 2016)

Am.

(endorsing HMT) ;

Express Co., 838 F.3d at 198-99 (2d Cir . 2016)

("[T]his Court

27

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 27 of 88

often applies a ' hypothetical monopolist test [ .] ' ).

Pl aintiffs '

In

factors .

third proposed methodology is

Brown

Shoe ,

the

Court

the

endorsed

Brown

Shoe

considering

the

following factors when defining a product market :

"industry or

public recognition of the submarket as a separate economic entity ,

the product ' s peculiar characteristics and uses , unique production

facilities ,

price

distinct customers ,

changes ,

and

distinct prices ,

sensitiv i ty to

vendors."

U. S.

special ized

370

at

325.

Notably, the D. C . Circuit has observed that some of these factors

are

merely

" evidentiary

substitutability. "

proxies

for

direct

Rothery Storage , 792 F . 2d at 218.

court noted that while

proof

of

The Rothery

sensitivity to price changes ,

distinct

prices , and unique production facilities " relate directly to the

economic definition of the market," the other factors

require

inferential reasoning to draw economic conclusions and "may be

he l pful where the other indicia are ambiguous . "

Turning

to

Defendants'

arguments,

I d. at 2 1 8 n . 4.

the

court

finds

unpersuasive Defendants' contention t hat Plaintiffs must explain

in their complaint why certain Ais or crop-protection products are

excluded

from

the

markets.

To

the

extent

Defendants'

cases

demonstrate a burden on antitrust plaintiffs to explain a negative,

t h ey are either anoma l ous or distinguishabl e.

For exampl e ,

in

Bayer- Schering , 813 F. Supp . 2d 569 , the court appeared to apply

enhanced

scrutiny

to

the

alleged

product

market

because

28

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 28 of 88

the

counterclaimant amended its product market inconsistently with its

original

counterclaim.

Id.

at 576 - 77

pleadings counsel that this Court

counterclaims

in

ensuring

standards.") .

Through this lens ,

("Sandoz ' s

closely scrutinize the amended

that

they

meet

I d.

Rule

12 (b) (6)

the court analyzed particular

alternatives outside of the alleged market,

appears,

contradictory

many of which ,

it

the counterclaimant introduced into the record itself .

Wh atever caused the Bayer-Schering court to impose this burden

and analyze particular products, the Fourth Circuit has suggested

that such scrutiny is misguided on a motion to dismiss .

Kolon,

637 F . 3d at 442

fact-intensive

inquiry ,

See , e . g. ,

("Because market definition is a deepl y

courts

hesitate

to

grant

motions

to

dismiss for failure to plead a relevant product market." (quoting

Todd, 275 F.3d at 1 99-20 0 )).

Defendants'

other cases

fare no better .

For example ,

in

Therapearl, LLC v . Rapid Aid Limited, Civil No . 13- 2792 , 2014 WL

4794905 (D . Md. Sept. 25 , 20 1 4) , the court dismissed a Sherman Act

claim for failure to plead a produ ct market because the plaintiff

did not even attempt an exp l anation of why the market was l imited

and

"made

no

interchangeability.

allegations

concerning"

reasonable

In Global Discount Travel Services ,

LLC v.

Trans World Airl ines , Inc., 960 F. Supp. 702 , 706 (S . D.N.Y. 1997) ,

the court found the product market was improperly pleaded because

the plaintiff included only its brand in the product market and

29

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 29 of 88

made no plausibl e exp l anation as to why other competitors did not

suppl y interchangeable products.

Division for Yout h ,

And in Chapman v . New York State

546 F . 3d 230 , 238

(2 d Cir . 2008) ,

the court

found a product market too narrow where the plaintiff did not

provide "any theoretically reasonable explanation for restricting

the product market . "

Here ,

Plaintiffs have

included such an

explanation and include in the market products beyond just those

of Defendants (namely , t h e generics).

Moreover,

the

court

is

unpersuaded

that

taking

judicial

notice of the EPA label registrations and FTC and DOJ antitrust

matters would materially a l ter the court ' s anal ysis at this stage.

While the court ,

under Federal Rule of Evi dence 20 1,

may take

judicial notice of facts that are " matters of public record,"

Justice

360

v.

Stirling ,

42

F.4th

450,

455

(4th Cir .

2022) ,

Defendants ask the court to also accept their interpretation of

facts within the cited publ ic records .

be probative of interchangeability,

interchangeable

function ,

not

The EPA registrations may

but they appear to speak to

whether

and

how

these

crop­

protection products are interchangeable in the marketpl ace - i.e.,

cross-elasticity of demand.

(finding

it

"immaterial "

In re Nexium, 968 F . Supp . 2d at 388

on

a

motion

to

dismiss

that

other

ph armaceuticals coul d be used to treat the same symptoms because

function does not necessarily speak to cross- elasticity of demand

among consumers) .

At a minimum, the EPA label registrations raise

30

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 30 of 88

fact

questions,

pleading

which are ill-suited for

stage .

And

whi le

the

prior

determination at

FTC

and

DOJ

the

antitrust

proceedings may suggest some inconsistency in how the government

views the crop-protection product market, the court must consider

each antitrust dispute on a case-by-case basis.

504 U. S .

at 467

Eastman Kodak,

(demonstrating preference to resolve antitrust

claims "on a case-by-case" basis);

(See Doc. 100 at 41-42 (citing

Ciba-Geigy Ltd . , 62 Fed. Reg. 409, 412 (FTC Jan. 3, 1997), because

FTC alleged in merger action a broader product market of "corn

herbicides") .)

As a result, even if the court took judicial notice

of these facts outside of the record, they woul d not materiall y

impact the court ' s analysis at this stage .

Defendants' other arguments fall short as well.

have

alleged plausible ,

albeit

narrow ,

product

Plaintiffs

markets .

The

reasoning applied in cases analyzing the relevant product market

for pharmaceuticals, specificall y that a p l ausible product market

may consist of a brand chemical and its generic alternative, is

instructive.

Zetia,

See In re Nexium, 968 F . Supp . 2d at 388 - 89; In re

2021 WL 6689718 at *19

consisting

of

Additionally ,

brand

drug

(finding proper a product market

and

generic

on

summary

judgment) .

Plaintiffs have plausibly al l eged facts that show

that there is limited cross-elasticity between the products inside

and

outside

of

Plaintiffs'

alleged

markets .

For

example,

Plaintiffs allege that Defendants' prices would fall significantly

31

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 31 of 88

upon entry of a generic of the same AI.

(See Doc. 149 <Jl.<Jl. 92 , 121 ,

127, 144, 150 , 158; Doc . 81 <Jl.<Jl. 101, 11 9 (demonstrating anticipated

market devaluation upon generic entry) . )

The alleged effect on

price result ing from generic entry plausibly suggests that the AI

i n each alleged product market does not already fac e substantial

competition from products outside the alleged market.

&

Hovenkamp,

supra

<JI

56lb2

(" [I] f

See Areeda

the price of one incumbent

product drops signi ficantly in response to new entry, while the

prices

of other

product,

plus

incumbents

the

new

do

not ,

then

that

is

very

likely

entrant ,

first

a

incumbent

market.").

Moreover, Defendants ' own alleged conduct, namely that Defendants '

own loyalty programs cover only individual Ais, plausibly suggests

that Defendants view the market as including only one AI b ut not

o t hers.

(Doc. 149

<Jl.<Jl.

67, 76); Todd,

275 F . 3d at 205

(crediting

evidence of defendant's conduct as suggestive of scope of product

market) .

Finall y,

Plaintiffs p lausibly allege characteristics

t hat make each AI unique in t he marketplace , that alternatives are

not considered by farmers as suitable ,

specific Ais.

and that farmers prefer

(Doc . 149 <Jl.<Jl. 46, 157 . )

In sum, Plaintiffs have alleged a plausible explanation as to

why the market should be limi ted as alleged .

at 442.

Cf. Kolon, 637 F.3d

Whether, as Defendants argue, they have the better of the

argument after the facts develop ,

must await another day .

and the evidence is weighed,

As a result, Defendants ' motion to dismiss

32

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 32 of 88

for fai l ure to plausibly al l ege a product market will be denied.

2.

Anticompetitive Conduct and Injury

Defendants argue that Plaintiffs have not plau sibly alleged

anticompetitive conduct and inj ury .

25.)

(Doc . 95 at 2 1 ; Doc . 100 at

The parties dispute first which legal test the court should

apply to Defendants '

loyalty programs, and second,

depend ing on

the test applied, whether Plaintiffs have alleged anticompetitive

conduct and i njury .

The

court considers each in turn for the

purposes of the instant motion .

a.

The Rule of Reason and Price-Cost Test

Defendants urge the court to apply the "price- cost" test,

argu ing that Plaintiffs failed to allege facts to survive this

measure of anticompetitive conduct.

22-23.)

(Doc. 95 at 24 ; Doc. 100 at

As suggested by its name , where the price-cost test is

applied, alleged condu ct may only be illegal if the price is set

bel ow the cost .

Brooke Grp. Ltd . v . Brown & Williamson Tobacco

Corp . ,

2 0 9,

50 9 U . S .

222

( 1993) .

Plaintiffs appear to concede

that the complaint does not allege prices below cos t.

(Doc. 150

at 43

("Pl aintiffs do not bring a predatory-pricing claim . ").)

This

concession

antitrust

claims

maintai n, however ,

would

seemingly

short-circuit

Plaintiffs'

if

price-cost

test

Plaintiffs

the

applies .

that the court would gravely err in apply i ng

the price- cost test , arguing instead t hat the cour t must apply the

defau lt "ru le of reason."

(Doc. 150 at 39-40 . )

Under that test ,

33

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 33 of 88

an exclusive dealing arrangement is unlawful only if its "probable

effect" is to substantially lessen competition in the relevant

market.

Tampa Elec., 365 U.S . at 327-29.

As a matter of principle, antitrust law is not intended to

prevent all price-cutting.

Brooke Grp . ,

509 U. S.

at 223

(" Low

prices benefit consumers regardless of how those prices are set,

and so

long as

t hreate n

they are

(quoting

competition."

Petroleum Co.,

above predatory levels,

495 U.S . 328, 340

Atl.

Richfield

(1990)).

they do not

Co.

In fact,

v.

USA

competitors

should generally be enabled to cut prices to a certain extent even to

increase market

antitrust laws .

share -

without running afoul of the

Id . ("The antitrust laws require no such perverse

result." (quoting Cargill, Inc. v. Monfort of Colorado, Inc., 479

U. S. 104, 116 (1986)).

generally

Low prices that are still above-cost are

procompetitive

because

"the

exclusionary

effect

of

prices above a relevant measure of cost [generally] reflects the

lower cost structure of the alleged predator, and so represents

competition on the merits."

On

the

other

hand,

Id . at 222 - 24.

predatory pricing

harms

competition.

Predatory pricing occurs where a company sets prices below cost to

eliminate competitors in the short run and reduce competition in

t he long run.

Cargill, 479 U.S. at 117.

Such a pricing scheme is

"rarely tried, and even more rarely successful."

Matsushita Elec .

Indus. Co. v. Zenith Radio Corp . , 475 U.S. 574 , 589 (1986).

"For

34

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 34 of 88

such a scheme to make economic sense ,

l osses

suffered

during

supracompetitive phase . "

Weyerhaeuser Co.

v.

the

the firm must recoup the

below-cost

ZF Meritor,

phase

in

696 F . 3d at 272

Ross-Simmons Hardwood Lumber Co.,

the

(citing

54 9 U.S.

312, 318 (2007)).

To separate the competitive wheat from the predatory chaff,

the Supreme Court devised the price-cost test: to succeed on a

predatory pricing claim, a plaintiff must demonstrate

(1)

"that

the prices complained of are below an appropriate measure of [the

defendant's] costs"; and (2) that the defendant had "a dangerous

probability

prices."

of

Id .

recouping

its

investment

(quoting Brooke Grp .,

509 U. S .

in

below-cost

at 222-24) .

In

fashioning this formalistic approach, the Court acknowledged that

the price-cost

test will miss

some

anticompetitive

above-cost

pricing , but that it "is beyond the practical ability of a judicial

tribunal"

to

ascertain

whether

above-cost

pricing

is

anticompetitive "without courting intolerable risks of chilling

legitimate price- cutting."

Id. at 273.

Where the price-cost test does not apply, courts apply the

rule of reason to exclusive dealing arrangements . 7

Tampa Elec . ,

7

The ZF Merit or court indicat ed that t he price-cos t t est is a "specific

applicat ion of t he rule o f reason" when applied in the cont ext of

exclusive dealing.

ZF Meritor, 696 F.3d at 273; see also In re EpiPen

(Epi nephrine Injection, USP) Ant i t rust Lit ig., 44 F.4 t h 959, 983 n.7

(10th Cir. 2022) (quot ing ZF Merit or's "specific application" language

and referring to the Tampa Electric analysis as the ''full rule of reason

35

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 35 of 88

365 U.S. at 327.

"[E ] xcl usive dealing arrangements violate the

antitrust laws only if they are likely to foreclose the entry in to

a substantial part of the market of products that compete with the

products

benefitting

from

the

exclusive

dealing

arrangement."

Chuck's Feed, 810 F.2d at 1293 (citing Standard Oil Co. v. United

States, 337 U.S . 293, 314 (1949)) .

following

considerations

when

The Supreme Court set out the

analyzing

an

exclusive

dealing

arrangement:

[T] he probable effect of the contract on the relevant

area of effective competition, taking into account the

relative strength of the parties, the proportionate

volume of commerce involved in relation to the total

volume of commerce in the relevant market area, and the

probable immediate and future effects which pre-emption

of that share of the market might have on effective

competition therein .

Tampa Elec . ,

365 U. S. at 329.

The concern of t he courts about

exclusive dealing arrangements is "the possibility that a single

manufacturer will control all or a

substantial number" of the

available options for a certain kind of product in a specified

geographical area.

Chuck's Feed,

810 F.2d at 1293

(addressing

concern in the context of retail markets)

To succeed on an exclusive dealing claim, a plaintiff must

analysis") ; UniStrip Techs. , LLC v. LifeScan, Inc., 153 F. Supp. 3d 728,

736 (det ermining whether to apply the "'price cos t t est' or the 'rule

of reason'"); In re Surescripts Antitrust Litig ., 608 F. Supp . 2d 629,

636 (N.D. Ill . 2022) (describing the "apt test" as the " rule of reason,"

as opposed to the "price-cost test"); cf. Atl . Richfield, 495 U.S . at

342 ("Per se and rule-of-reason analysis are but two methods of

determining whether a restraint is "unreasonable," i .e . , whether its

anticompetitive effects outweigh its procompetitive effects . ").

36

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 36 of 88

prove (1) the rel evant product market ;

(2) the geographical area

of competi t ion for the product market ; and (3 ) that the arrangement

at issu e extends to a " substantial share of the relevant market . "

Id.

(citing Tampa Elec .,

substan tial

foreclosure,

365 U.S .

327-28).

it

still

must

If a

court finds

consider

"whether

an

otherwise unacceptable level of market foreclos u re is justified by

procompetitive efficiencies . "

Id . at 1294

(citing Cont ' l

T.V .,

I nc. v. GTE Sylvania , I nc ., 433 U. S. 36, 57-58 (1 977); Arizona v.

Maricopa Cnty . Med . Soc ' y , 457 U. S . 332 , 343 (1 982) ) .

Substantial

foreclosure has been found " even though the contracts foreclose[d]

l ess than [a) roughly 40% or 50% share."

Microsoft, 253 F . 3d at

70 (Sherman Act§ 2 claim).

The Supreme Court's price- cost line of cases demonstrates

that the price-cost test applies at least where a pricing practice

itself operates as the e x clusionary tool ,

plaintiff

styles

i ts

allegations .

In

regardless of how the

Pacific Bell

Telephone

Company v. Linkline Communications , Incorporated, for example, the

defendant , which sold input s at wholesale and finished goods at

retai l , allegedly drove competitors out of the market by raising

the

wholesale

price.

price

simultaneously

555 U. S . 438 , 457 (2 009) .

" price-squeezing"

scheme

while

was

claim

permissible

remain[ed] above cost . "

lowering

the

retail

The Supreme Court analyzed this

under

Brooke

because

"the

Id. at 451-52.

Group,

holding

defendant' s

that

ret ail

the

price

In Cargill , Incorporated

37

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 37 of 88

v. Monfort of Colorado, Incorporated, the Supreme Court rejected

a

plaintiff's

theory

of

antitrust

injury where

the

plaintiff

alleged that the defendant's merger would lead to reduced prices

that were still at or above cost.

479 U.S. at 114-16.

And in

Atlantic Richfield Company v. USA Petroleum Company, the plaintiff

alleged that the defendant, a gasoline manufacturer, had engaged

in price-fixing by offering its dealers discounts and rebates to

stave off competition from independent dealers.

32 .

495 U.S. at 331-

The Supreme Court held that where a firm or group of firms

lowers prices through a vertical agreement, but maintains prices

above cost, competitors ' losses are attributable to procompetitive

forces , not anticompetitive predatory pricing .

Id. at 337-38 .

Lower courts have nevertheless grappled with the question of

when to apply the price-cost test when it is not clear that a

company engages merely in "price- cutting" - e.g . , when a company

offers discounts in exchange for purchasing a certain percentage

of goods from that company .

To be sure, courts have in some cases

applied the test to above- cost discounting in such instances .

For

example, in NicSand Incorporated v . 3M Company, two suppliers of

automotive

sandpaper

competed

for

business

with

retailers that controlled 80% of the retail market .

447 (6th Cir . 2007).

six

large

507 F.3d 442,

Five out of the six retailers sold only one

brand at a time, meaning each retailer sold only either NicSand or

3M, but not both .

Id.

In order to obtain that exclusive shelf38

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 38 of 88

space ,

NicSand or 3M had to offer a favorable price and meet a

number of additional terms,

such as providing a

fu ll

line of

automotive sandpaper and providing the racks for the shelves.

at 448.

Id.

For years , NicSand dominated the shelves in four of the

five retailers that insisted on single-brand shelves.

That is,

until 3M offered retailers up-front payments worth hundreds of

thousands of dollars in exchange for switching to 3M.

Id.

The

Sixth Circuit applied the price-cost test in rejecting NicSand ' s

claim.

In doing so ,

the court reasoned that exclusivity was an

essential

feature

of

this

specific

retai l ers

(i.e. ,

the

buyers)

retail

required

market

because

exclusivity,

and

the

that

NicSand, as the market incumbent , could not now complain that 3M

had knocked it from its perch using similar exclusive terms it had

previously utilized.

Id. at 456

("When one exclusive dealer is

replaced by another exclusive dealer , the victim of the competition

does not state an antitrust injury. " ).

Ul timate l y, the court found

that the up-front payments 3M offered were a pricing measure that

the re t ailers "insisted on receiving" in order to switch suppliers .

Id. at 453.

The Eighth Circuit, in Concord Boat Co rporation v . Brunswick

Corporation , 207 F.3d 1039 (8th Cir . 2000), applied the price-cost

test to the plaintiffs' Sherman § 2 claim and the rule of reason

to the plaintiffs ' Sherman§ 1 claim, albeit with little discussion

as

to why the cou rt applied different tests

to

the different

39

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 39 of 88

claims.

The defendant, Brunswick, offered market-share discounts

to boat builders and dealers in order to increase the sales of its

engines .

Id . at 1044.

From 1995 to 1997, Brunswick offered a 3%

discount

if

purchased

a

buyer

70%

of

its

engines

from

the

defendant, a 2% discount for 65% of its engines, and a 1% discount

for 60% of its engines.

Brunswick also offered additional

Id .

discounts to anyone who signed a multi-year market-share agreement

and to t hose who purchased a higher volume of engines

volume discount) .

Id.

(i.e., a

Analyzing the plaintiffs' section 1 claim

under the rule of reason because the plaintiffs did not allege

activity that would "trigger a per se analysis," the Eight Circuit

held that the plaintiffs

failed to establish that Brunswick's

discount program was anticompetitive exclusive dealing because

boat builders were not required to commit for a specified time

period and many had switched to other sellers when offered superior

discounts.

Id. at 1058-59.

plaintiffs

did

not

show

Moreover, the court held that the

that

"significant

barriers

to

entry

existed" in the market because firms had little difficulty entering

t he market.

Id.

Then, applying the price-cost test to plaintiffs '

section 2 claim, the court held that Brunswick's loyalty program

was a "normal competitive tool" because its prices remained above

variable cost.

justify this

Id. at 1062.

holding,

the

Though not apparently necessary to

court

reiterated that

t he

discount

program was not exclusive dealing, that the boat builders could

40

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 40 of 88

walk away at any time (and did so), and that there were low barriers

to entry.

Id. at 1063.

Equipped with

these

precedents,

t he

Third Circuit

in

ZF

Meritor dealt more explicitly with which of the two tests to apply

when presented with another loyalty discount program.

In that

case, the defendant, Eaton, had about an 80% market share in the

manufacture

of

heavy-duty

truck

transmissions

and

introduced

loyal ty contracts t hat provided both upfront payments and rebates

to

four

major

truck

transmissions .

manufacturers

ZF Meritor,

t ha t

696 F.3d at 265,

purchased

truck

286 n.5.

These

contracts lasted for at leas t five years and would scale discounts

based on the percentage of goods the manufacturers purchased from

the defendant.

Id. at 265.

ranged from 85% to 95%.

beyond

the

Generally, the market-share targets

Eaton included additional terms

Id .

discounts.

Notably,

Eaton

retained

the

right

to

termi nate the agreements if the market share figures were not met,

and if the manufacturers did not meet the market-share figure for

one

year,

savings."

Eaton

could

require

Id.

Moreover,

"repayment

all

contractual

direct-from-manufacturer truck buyers

could customize certai n equipment,

including transmissi ons,

could browse options in the manufacturers'

agreements required t hat

of

its

catalogues.

transmissions be

and

Eaton's

fea tured as

the

standard offering in the catalogues and even required the removal

of

competitors'

products

in

two

of

the

four

manufacturers'

41

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 41 of 88

catalogues.

Id.

Further,

the manufacturers were contractually

required to price competitors' products above those of Eaton.

Id.

at 265-66.

The ZF Meritor court weighed whether to apply the price-cost

test or the rule of reason to Eaton's agreements.

Id . at 268.

The court noted that the price-cost test "would control if this

case presented solely a challenge to Eaton's pricing practices."

Id.

at

273-74.

However,

the

court

credited

testimony

that

demonstrated that manufacturers were forced to meet the market­

share targets , or else risk financial penalties, supply shortages ,

or severed ties with t he market-dominant defendant entirely.

at 277.

Because Eaton was

a

monopolist,

Id.

the court reasoned,

forgoing the rebates and "losing Eaton as a supplier was not an

optio n."

The

Id. at 278.

court

defendant's

stated that

low price was

"this

is not a

the clear driving

customer's compliance with purchase targets,

case

in which the

force

behind the

and the customers

were free to walk away if a competitor offered a better price ."

Id.

(citing Concord Boat, 207 F.3d at 1063 as a counter-analogy).

Put another way, Eaton ' s de facto exclusive dealing arrangements

drove out other firms "not because they cannot compete on a price

basis, b ut because they are never given an opportunity to compete,

despite their ability to offer products with significant customer

demand."

Id . at 281 .

The court held that when price itself is

42

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 42 of 88

not the "clearly predominant mechanism of exclusion ," the priceId. at 277. 8

cost test does no t app l y.

A few years later , the Third Circuit revisited ZF Meritor in

the pharmaceutical context .

Eisai, Inc . v. Sanofi Aventis U.S.,

LLC ,

821 F . 3d 394

(3d Cir. 2016) .

In that case, Eisai alleged

that

Sanofi Aventis engaged i n three modes of anticompetitive

conduct in the market for anticoagulant drugs in U.S. hospitals:

" ( 1)

market-share

and

volume

discounts,

( 2)

a

restrictive

formulary access clause, and (3) aggressive sales tactics used to

market the program."

Id. at 400.

Specifically, Sanofi offered a

baseline 1% discount for a market-share below 75% and a scaled

discount from 9% to 30% for market-shares above 75% .

Id .

The

court ultimately held that Sanofi ' s program was distinguishable

from that in ZF Meritor because the discounts were not de facto

mandatory , did not threaten repayment of contractual savings , and

did no t t hreate n refusa l t o dea l in t he future.

Id. at 406.

The

cou rt nevertheless refrained from commenting on whether the price-

8

In dissent , Judge Greenberg disagreed wit h t he majority 's view that

the agreement s were exc l usive dealing and inst ead would have applied the

price-cost

t est.

ZF Meritor ,

696 F.3d a t

349 (Greenberg , J .,

dissent ing).

He

principally

d isagreed

wi t h

the

majorit y's

characterization of Eaton's conduct as coercive, as he viewed the

agreements as neither exclusive nor mandatory and contended t hat there

was no evidence " t hat Eaton would have refused to supply t ransmissions

to the [manufacture rs]u if they failed t o meet t he market share targets.

Id . at 312 . Moreover, Judge Greenberg took the position t hat the price­

cos t test should apply in a situation such as this because the agreements

themselves - with or without non-price f eatures - woul d not exist

"without the reduced prices that Eaton offeredu as an incentive to enter

the agreement in the first p lace . Id . at 321 .

43

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 43 of 88

cost test applied because,

applied

in

ZF Meri tor,

even under the rule of reason test

the p laintiff 's

claims

insufficient evidence of market foreclosure.

failed

due

to

Id. at 408-09 .

The Thi rd Circuit's approach suggests that loyalty discount

arrangements may be pure (or nearly pure) pricing schema, and in

such situations, the price-cost test applies neatly .

NicSand,

other

507 F.3d at 453.

allegedly

coercive

However,

See, e . g . ,

an arrangement may include

mechanisms

that

impose

costs

on

competitors to enter the market such that price is not "clearly"

doing

the

work

formulation,

of

exclusion.

Following

the

Third Circuit 's

other circuits have since relied upon and cited ZF

Meritor where the defendant offers loyalty discounts.

See, e.g . ,

In re EpiPen (Epinephrine Injection, USP) Antitrust Litig., 545 F.

Supp.

3d 922,

1016-17

(D.

Kan.

2021)

(explicitly applying the

"clearly predominant mechanism of exclusion" analysis), aff'd , 44

F.4th 959 (10th Cir. 2022)

(observing that ZF Meritor and other

Third Circuit precedent "merit close consideration in this case");

McWane, 783 F.3d at 835

(citing ZF Meritor to just ify a rule of

reason approach to exclusive dealing cases); Aerotec Int 'l, Inc.

v . Honeywell Int'l, Inc . , 836 F . 3d 11 7 1, 1182-83 (9th Cir. 2016)

(citing ZF Meritor as a counter-analogy for situation with " extra­

contractual conditions,

or preferential treatment terms");

see

also Dial Corp . v. News Corp., 165 F . Supp. 3d 25, 32 (S.D.N.Y.

2016)

(citing

and

applying

ZF

Meritor's

"clearly

predominant

44

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 44 of 88

method

of

exclusion"

test

in

non-loyalty

discount

exclusive

dealing case) .

ZF Meri to r

Supreme

Court

appears

has

to balance the important concerns

identified

in

over-regulating

the

price-cutting

schema, see Matsushita , 475 U.S . at 594 ("[M]istaken inferences in

[pricing cases]

chill

the

very

cases

conduct

are especially costly, because they

the

antitrust

l aws

are

designed

to

protect."), and under-regulating exclusive dealing, see Jefferson

Par., 466 U.S . at 45 (O'Connor, J. , concurring) ("Exclusive dealing

can have adverse economic consequences by allowing one supplier of

goods or services unreasonably to deprive other suppliers of a

market for their goods [.] ") .

The ZF Meri tor approach counsels

applying the price-cost test where a pricing practice is clearly

doing the work of exclusion and the rule of reason where there are

mechanisms

beyond

price-cutting

that

exclude

competition

by

imposing unilateral costs on competitors.

The parties do not appear to disagree with the above analysis.

(Doc. 100 at 25; Doc. 95 at 24-25; Doc. 150 at 41 .)

Rather, they

depart on whether price clearly predominates over other mechanisms

of exclusion in this case.

Syngenta argues that Plaintiffs do not

plead " any of the non-price coercive features that courts have

required"

before

anticompetitive.

finding

market-share

a

(Doc . 100 at 27 .)

rebate

program

Furt her , Syngenta argues, the

single-year and single-product scope of the

rebates

undermines

45

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 45 of 88

Plaintiffs '

claim that price clearly predominates.

Syngenta dismisses Plaintiffs'

distributor

as

an

"isolated

(Id. at 29.)

allegation that it terminated a

allegation"

probative of the program itself."

that

is

"simply

not

(Id. at 30 (emphasis removed) .)

Finally, Syngenta characterizes Plaintiffs' allegations regarding

Defendants' agreement whereby Syngenta supplies mesotrione ands­

metolachlor for Corteva's use as an "effort to muddy the waters."

(Id. at 32.)

Corteva first argues that "Plaintiffs' allegations make clear

that price is the primary means of exclusion, but do not allege

that Corteva's programs fail the price-cost test."

25.)

(Doc. 95 at

Corteva specifically contends that Plaintiffs do not allege

long-term

contract

noncompliance,

terms

which

are

or

exclusions

recognized

from

supply

non-price

would trigger the default rule of reason.

based

conditions

(Id . at 26.)

on

that

Second,

Corteva claims that its term that defers a certain percentage of

rebates

into subsequent years

and retracts

unpaid rebates

for

noncompliance is "no more than a 'threat of a lost discount'" that

is, in its view, not anticompetitive.

(Doc . 98 at 26.)

Third, Corteva claims that conditioning the Corporate Offer

on compliance with the CRPIVM is not anticompetitive "bundling."

(Id. at 27-28.)

goods

Bundling occurs "when a firm sells a bundle of

. for a lower price than the seller charges for t he goods

purchased

individually ."

Cascade

Health

Sols .

46

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 46 of 88

v.

PeaceHealth , 515 F . 3d 883 , 894 (9th Cir . 2008).

the

Corporate

Offer

"just

offers

an

In Corteva' s view,

additional

discount

to

Corteva's customers who do buy products covered by the [Corporate

Offer ] ."

"should

(Doc. 95 at 28 . )

not

nonspecific

credit

Fourth, Corteva contends that the court

[P]laintiffs '

allegations

that

unsupported ,

' Defendants

have

conclusory

and

retaliated

and

threatened to retaliate ' against distributors that have failed to

satisfy

l oyal ty

by

cance ll ing

distribution

contracts

or

withholding access to supply."

Plaintiffs argue in response that Defendants mischaracterize

their own discount program as a pricing scheme.

(Doc . 150 at 35.)

Plaintiffs point to the complaint ' s allegations that "Defendants

have

' threatened

distributors .

to

retaliate

against

[disloyal]

by canceling distribution contracts , de l aying

access to new products , or withholding product allocation during

a supply shortage. "

(Id . at 36 (citing Doc. 149 <I[ 88).)

Pl aintiffs

further maintain that they allege that each Defendant "follow [ed]

through"

on

their

threats

by

refusing

to

sell

pesticides

9

or

Corteva argues that this litigation was filed well over fou r years

after the loyalty programs were allegedly put in place, outside the four ­

year statute of limitations provided for in t he Sherman Act and Clayton

Act .

(Doc . 95 at 29 - 30.)

In its briefing on i t s motion to dismiss t h e

original complaint, Corteva argued t hat those claims therefore "long ago

expired . "

(Doc. 70 at 23-24 . ) Though Corteva does not claim that now,

and while Plaintiffs responded to Corteva ' s suggestion by noting, among

other bases, the continuing violation doctrine , (Doc . 150 at 67-68), the

court concludes that the issue is not fairly raised in Corteva ' s brief

and therefore does not consider i t .

47

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 47 of 88

limiting sales of an insecticide to two distributors.

at 36 (citing Doc. 81 1 88) .)

(Doc. 112

Plaintiffs respond to Defendants'

argument - that t hese are isolated incidents t hat do not exemplify

the program - by arguing that the reasonable inference which must

be

drawn

in

Plaintiffs'

favor

i ns tances

of

retaliation

are

working as intended.

(Id.

at

this

evidence

stage

is

of

loyalty program

at 37-38.)

the

that

limited

Plaintiffs also contend

that the one-year length of the agreements triggers no presumption

that the contracts are lawful and that looking to the practical

effect of agreements demonstrates " long-term foreclosure. "

at 38-39.)

(Id.

Plaintiffs finally argue that even if the price-cost

test applies to the Sherman Act and Clayton Act claims, it does

not apply to the FTC Act claim.

(Id. at 45- 47.)

In other loyalty discount cases, courts have observed a number

of

non - price

mechanisms

of

exclusion ,

such

as

provisions

aggravating existing barriers to enter the market , McWane, Inc.,

783 F.3d at 836; In re Surescripts Antitrust Litig ., 608 F . Supp.

3d

629 ,

645

exclusive

(N . D.

dealing,

Ill.

NicSand,

obligations to purchase a

defendant ,

2022) ;

whether

507

F. 3d

the

buyer

insists

at

456;

contractual

set percentage of products

Allied Orthopedic,

592

F.3d at

997

n .2;

on

from the

discounts

involving tying or bundling, Eisai , 821 F.3d at 405; LePage's, 324

F . 3d at 157 - 58 ;

t hreats to retract unpaid rebates or claw back

discounts from prior years, McWane, 783 F.3d at 820-21; threats to

48

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 48 of 88

cut off supply from a monopolist ,

ZF Meri tor ,

696 F. 3d at 27 8 ;

requirements to exclude competitors from marketing materials, id .;

and the length of time of the discounting agreements, McWane, 783

F.3d at 820-21.

While these cases are instructive, each antitrust

case "must be determined upon the particular facts disclosed by

the record, and . . . the opinions in those cases must be read in

t he

light

of

their

facts

and of

a

clear

recognition

of

the

essential differences in the fac ts of those cases, and in the facts

of any new case to which the rule of earlier decisions is to be

applied."

Maple Flooring Mfrs. Ass'n v. United States, 268 U.S.

563 , 579 (1925).

Here, Plaintiffs have alleged sufficient non-price mechanisms

of exclusion to foreclose application of the price - cost test as a

matter

of

law at

this

plausibly

alleges

that

Defendants '

monopolist

pleading

stage.

First,

the

loyalty

programs

status

and

t he

the

leverage

market's

barriers to entry to exclude competition for the Ais.

<J[

160.)

lega l

Among the alleged "capital,

barriers"

are

"obtaining

technical,

registration

complaint

the

substantial

(Doc. 14 9

regulatory and

from

the

EPA,

developing manufacturing processes and sourcing active ingredient,

and paying data compensation costs to the initial active ingredient

registrant."

While high entry barriers

alone may not

trigger the rule of reason, Plaintiffs have plausibly alleged that

Defendants' use o f the loyalty discounts - as alleged monopolists

49

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 49 of 88

relating to production of the Ais - exacerbates the already high

costs

to

enter

the

market by locking up

efficient channel of dist ribution .

access

to

the

most

See McWane , 783 F.3d at 836;

ZF Meritor , 696 F . 3d at 284-85 (app l ying rule of reason where high

barriers e x isted in high-concentration market ) ; Eastman Kodak, 504

U. S.

at

488 (Scalia,

J.,

("Behavior

dissenting)

that

might

otherwise not be of concern to the antitrust laws . . . can take

on exclusionary connotations when practiced by a monopo l ist.")

Second,

the

complaint

alleges

threatened to cut off supply,

not

only

that

Defendants

but that each Defendant followed

through on that threat, a l beit in l imited instances.

':II 8 8. )

(Doc. 1 49

While Defendants contend that these do not exemplify the

program,

the

court

must

draw

Plaintiffs' favor at this stage.

all

reasonable

inferences

in

Such instances plausibly support

the claim that Defendants' threats to restrict supply are effective

deterrence against non- compliance.

(See i d . ':II 84

(alleging that

Defendants

to

thresholds

communicate

distributors) . )

to

restrict

adherence

loyalty

to

The complaint plausibly alleges that the threats

suppl y

factors

into

distributors '

purchasing

decisions .

Third,

whi l e

the l e ngth of the agreements is facia l ly one

year, the alleged yearl y renewals and threat of retaliat i on are

claimed t o have a longer- term effect.

(Id .

':11':ll

164 , 172 . )

Further,

Corteva ' s agreements allegedly contain terms that defer payments

50

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 50 of 88

into subsequent years and require forfeiture of unpaid discounts

for non-compliance.

Fourth,

(Doc. 81

Corteva' s

<_![

78.)

agreements allegedly share some features

with bundling because Corteva offers terms that link discounts for

any one AI to compliance with the loyalty threshold fo r all Aisin

a distributor's offer and that link discounts under the Corporate

Offer to compliance with the CPRIVM offer.

Finally,

Plaintiffs

plausibly

allege

(Id.

<_![

that

79.)

the

Syngenta­

Corteva supply agreement for mesotrione and metolachlor allegedly

enhances the exclusive effect of the loyalty programs.

<_j[<_j[

(Doc. 149

109, 122.)

Whether these non-price mechanisms have the alleged exclusive

effect vis-a-vis

record.

price will

depend on the development of the

In light of these plausible allegations, Defendants have

not demonstrated at this stage that price clearly predominates

over non-price mechanisms of exclusion.

Defendants'

other

arguments

do

not

alter

this

analysis.

First, that t he loyalty discounts cover a single product

(i.e.,

each individual AI) does not necessarily mean that price clearly

predominates .

While Defendants cite to ZF Meritor and Eisai for

this proposition, neither supports it .

In ZF Meritor, the Thi rd

Circuit did state, "we join our sister circuits in holdi ng that

the price- cost test applies to market-share or volume rebates

offered by suppliers within a single-product market."

ZF Meritor,

51

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 51 of 88

696 F.3d at 274 n.11

(citing NicSand,

507 F . 3d at 452 ; Concord

Boat , 207 F.3d at 1061 ; Barry Wright , 724 F . 2d at 236) .

In making

this observation , the Third Circuit was distinguishing LePage's v.

3M, 324 F . 3d 131 (3d Cir. 20 03 ), where the court did not apply the

price-cost test because the alleged conduct involved "bundling"

across multiple products .

Id .

The court reasoned that LePage's

should not extend to the facts of ZF Meritor ,

product

is

at

issue

and

allegations of bundling . "

the

p l ainti f fs

ZF Meritor,

where "only one

have

not

made

any

696 F . 3d at 274 n . 11.

Though the court stated that the price-cost test " applies " to a

single-product discount, the ZF Meritor court itself applied the

rule of reason discount.

not the price-cost test -

to a single-product

This indicates that the price- cost test can apply where

there is a single-product market , not that it must .

reliance on Eisai fares no better ,

that

pricing

" usually"

Defendants'

as the Third Circuit stated

predominates

over

other

means

of

exclusivity when "a firm uses a single-product loyalty discount or

rebate to compete wi t h s.imilar products . "

Eisai , 821 F . 3d at 409 .

However, the court ultimately refrained from applying t he price­

c o st test because the plaintiff's claim failed under Tampa Electric

as well .

claims

Id .

are

at 409

("Because we have concluded that Eisai ' s

not

substantiated

a rule of reason analysis,

and

that

they

fai l

we will not opine on when ,

if ever,

the price-cost test applies to this type of claim . ") .

Notably ,

52

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 52 of 88

neither ZF Meritor nor Eisai was decided at the pleadings stage

but after the development of a factual record.

ZF Meritor was

decided on post-trial motion , and Eisai was decided on motion for

summary judgment.

Though the price-cost test may apply to certain

loyalty

programs ,

discount

the

Supreme

Court

admonishes

that

"[l]egal presumptions that rest on formalistic distinctions rather

t han actual market reali ties " are "generally disfavored" and that

courts should resolve anti trust cases on a

"focusing on the

Eastman Kodak ,

'particular facts

504 U.S .

at 466-67

case-by-case basis,

disclosed by the

record.'"

(quoting Maple Flooring,

268

U.S . at 579 ).

Second, at least at this early stage, it is not clear that

the single- year term of the loyalty discount agreements mandates

application of t he price-cost test as a matter of law.

Defendants

contend that the single- year term of their agreements in t his case

"are presumptivel y incapable of harming competition."

at 29 .)

While long-term exclusive dea ling has been found to factor

in favor o f finding anticompetitive injury,

at

(Doc. 100

286-87,

Defendants

have

not

ZF Meritor, 696 F.3d

demonstrated

t hat

a ny

such

presumption exists .

Rather,

t he cases Defendants cite for this

position

courts

have

show

determining

that

anticompetitive

anticompetitive effects.

weighed

effects,

not

short

presumed

duration

a

lack

in

of

See R.J. Reynolds Tobacco Co. v . Philip

Morris Inc ., 199 F . Supp . 2d 362, 391-93 (M.D.N.C 2002) , aff'd sub

53

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 53 of 88

nom. RJ Reynolds Tobacco Co. v.

App'x

810

(4th Cir.

2003)

Philip Morris USA,

(unpublished)

Inc.,

67 F.

(considering contract

length along with percentage of foreclos ure and costs of switching

to other vendors); see also In re EpiPen Mktg., 44 F.4th at 988

(" It

is

axiomatic

that

short,

easily

terminable

exclusive

agreements are of little antitrust concern; a competitor can simply

wait

for

the

contracts

to

expire

or make

alluring

offers

to

initiate termination." (collecting cases)); Allied Orthopedic, 592

F . 3d at 997

("The

'easy terminabili ty'

of an exclusive dealing

arrangement 'negate [s ] substantially [its] potential t o foreclose

competition.'" (quo t ing Omega Env't, Inc. v. Gilbarco, Inc., 127

F.3d 1157,

1163-64

(9th Cir .

1997))).

Here,

Plaintiffs allege

that Defendants' renewable single- year contracts create long-term

competitive harms, including cutting off supply and, in Corteva's

case,

deferring

rebates

into

subsequent

years

further compliance with meeting market-share.

F.3d at 193-94

conditioned

on

See Dentsply ,

399

(finding "strong economic incentive to continue"

compliance with market-share agreement despite "legal

which the relationship can be terminated"); McWane,

833-34

(finding

anticompetitive

injury

dealing was "short-term and voluntary").

even

ease with

783 F .3d at

though

exclusive

Moreover, each of the

Ais has been in a loyalty program for at least four years, and one

has been included for almost two decades.

115, 127, 137, 146.)

(Doc. 149

<J[<J[

93, 102,

While the annual length of the agreements is

54

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 54 of 88

generall y a factor that favors Defendants , the court must draw a l l

reasonabl e

inferences

from

the

compl aint ' s

Plaintiffs ' favor at this early stage .

a llegations

in

As such , the court cannot

say that the length of the agreements requires a finding at this

time that price clearly predominates over other alleged non-price

mechanisms of exclusion .

In sum, Pl aintiffs have plausibly alleged suffic i ent facts ,

if believed,

for

the court to concl ude

that price is not

clearly predominant mechanism of exclusion .

the

The complaint alleges

that Defendants are dominant suppliers who have entered into de

facto

exclusive

deal ing

arrangements

t h at

include

significant

mechanisms

Accordingly,

the court cannot conclude at this stage that the

of

beyond

plausibl y

exclusion

price-cost test must apply as a matter of law.

price-cutting .

Indeed, Defendants'

cited cases demonstrate that courts have reached , or even closely

considered,

such

circumstances.

to

dismiss

trial);

tria l

plaintiff

207 F . 3d 1039

ZF Meritor,

after

conclusion

before

discovery

in

only

rare

NicSand, 507 F . 3d 442 (price-cost applied on motion

where

Concord Boat,

a

did

have

antit r u st

standing) ;

(price-cost partially applied post­

696 F . 3d 254

extensive

not

(rule of reason applied post­

discussion) ;

(dismissing price- squeezing c l aim,

Pac .

Bell ,

555

U. S .

438

not excl usive d ealing c l aim).

Depending on the facts addu ced at a later stage, it remains to be

seen whether the price-cost test or Tampa Electric' s rule of reason

55

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 55 of 88

and its progeny will ultimately be the proper test for Plaintiffs '

claims.

For purposes of the pending motions, therefore, the court

turns to Defendants' contention that the complaint fails under the

rule of reason.

b.

Defendants

Allegations

Injury

argue

that

of

Anticompetitive

Plaintiffs

anticompetitive conduct and injury .

have

failed

Conduct

to

and

al l ege

Corteva contends that it is

" entirely dispositive" that Plaintiffs have not pled any actual

exclusivity because the loyalty programs are voluntary,

cover all distributors in the market,

exclusivity.

that

any

(Doc.

market

95 at 22-23 . )

foreclosure

is

do not

and do not require 100%

Syngenta principal ly argues

the

result

of

"lawful

price

competition," that Syngenta incentivized customers to "buy more of

its products by lowering its prices," and that there is an absence

of non-price mechanisms of exclusion present in other cases like

ZF Meritor and Dentsply.

(Doc. 100 at 33-35 . )

Syngenta further

argues that Plaintiffs failed to explain why generic competitors

do not lower their prices to make their products more profitable

to distributors.

(Id. at 35.)

Finally, Syngenta claims that its

exclusive dealing arrangement with Corteva is evidence of legal

competitive conduct.

Plaintiffs

(Id . at 36-37.)

respond

that

they have plausibly alleged both

indirect and direct evidence of harm to competition.

(Doc. 150 at

56

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 56 of 88

26.)

On the indirect side ,

Plaintiffs contend that they have

a lleged foreclosure of a " substantial part of the market."

(citing Chuck's Feed, 810 F . 2d at 1293-95) .)

contend

that

Defendants

have

Doc. 81

<JI

171) . )

Sp ecifically, they

foreclosed

"approximately 70% or more" of the market.

(Id.

generics

from

(Doc . 112 at 27 (citing

Plaintiffs further argue that this estimate is

likely conservative because it relies on the lowest market-share

thres hold available and conservatively assumes that distributors

only narrowly hit the market-share threshold .

(Doc . 150 at 27 . )

On the direct side , Plaintiffs argue that they have alleged three

competitive harms : reduced choices for farmers , higher prices for

farmers ,

and less innovation .

contend

that

Defendants '

(Id . at 28 . )

discounts

may

Plaintiffs further

benefit

distributors but do not get passed on to farmers.

participating

(Id. at 35 . )

As an initial matter , Defendants ask the court to apply the

same mode of inquiry , i.e. , the ru l e of reason or price-cost test

- regardless of the antitrust statute at issue .

13.)

(Doc . 157 at 33 : 7-

Indeed, courts have conducted the exclusive dealing inquiry

in such a manner.

See ,

e.g.,

ZF Meritor,

696 F.3d at 269 n . 9

(stating that the r u le of reason is applicable to the plaintiff ' s

claims under Sections 1 and 2 of the Sherman Act and Section 3 of

t h e Cl ayton Act);

Microsoft,

253 F. 3d at 59

reason to Sherman Sections 1 and 2) ;

1294

(appl ying ru l e

Chuck' s Feed,

of

810 F. 3d at

(appl ying rule of reason to exclusive dealing under the FTC

57

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 57 of 88

Act and Clayton Section 3).

Moreover, Defendants do not argue that Plainti ffs ' c l aims may

survive under some antitru st statu tes b u t not others , at least at

this stage.

the

Here , the relevant threshold requirements specific to

statutes

are Sherman Section 1 ' s

contract requirement ,

15

U. S.C. § 1 ("Every contract . . . "), Sherman Section 2 ' s monopoly

power

requirement ,

15

U. S . C.

§

2

( " Every

person

who

shall

monopolize . . . "), and Clayton Secti on 3 ' s conditional discount

or rebate requirement,

15 U. S . C.

§

1 4 (".

. discount from,

rebate u pon , such price, on the condition .

.") .

or

Defendants do

not appear to contest that these requirements are a l leged, so the

court will treat them as uncontested for the purpose of these

motions.

Boles v.

(M . D.N.C. 20 1 4) .

United States ,

3 F.

Supp .

3d 491,

507 n.10

In any event, it appears that Plaintiffs have

adequately pleaded these elements.

Kolon , 637 F . 3d at 450 (" [T]his

Court has previously noted that when monopolization has been found

the defendant controlled seventy to one hundred per cent of the

relevant market . "

<_![<JI

81 ,

84,

161-63

(internal quotat ion marks omitted)) ;

(al leging agreements with

(Doc . 150

substantially al l

leading distribu tors; market share in excess of 70% during relevant

time period for five of six Ais and 40% for Corteva ' s acetochlor

(based on its joint venture partner h aving approximately 50%); and

conditional payme n ts).)

To prevail , Plaintiffs must plausibly allege that Defendants '

58

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 58 of 88

loyalty agreements constitute anticompetitive conduct and caused

antitrust injury.

issue,

there

Microsoft , 253 F.3d at 58-59 .

is no

set

formula to demonstrat e

conduct under the rule of reason.

As to the first

anticompetitive

ZF Meritor 696 F.3d at 271.

Courts have considered

a showing of significant market power by the defendant ,

substantial

foreclosure,

contracts

of

sufficient

duration to prevent meaningful competition by riva l s , []

an analysis of likely or actual anticompetitive effects

considered in light of any procompetitive effects [,]

whether there is evidence that the dominant firm engaged

in coercive behavior , [] the ability of customers to

terminate the agreements [, and t Jhe use of exclusive

dealing by competitors of the defendant[ . ]

ZF

Meritor,

696

F.3d

(collecting cases) .

at

271-72

(internal

An allegation of a

foreclosure is not required.

citations

omitted)

percentage of market

Kolon , 637 F.3d at 452 n.12 .

As to

the second issue, an antitrust injury is "of the type that the

statute was intended to forestall"

Microsoft ,

253 F . 3d at 59

(quoting Brunswick Corp. v. Pueblo Bowl-0-Mat , I nc., 429 U.S. 477,

487-88 (1977))

brought

by

(internal quotation marks omitted) .

t he

Government,

it

must

"[I]n a case

demons t rat e

that

the

monopo l ist ' s conduct harmed competition , not just a competitor."

Id.

Section 1 and 2 of the Sherman Act and Section 3 of the

Clayton Act require different degrees of

substantial ity.

The

Supreme Court has implied in dic t a that Section 3 of the Clayton

Act requires a lesser showing than the Sherman Act does:

"[I]f

59

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 59 of 88

[the contract] does not fall within the broader proscription of

§ 3 of the Clayton Act it follows that it is not forbidden by those

of the [Sherman Act]."

Tampa Elec . ,

365 U. S . at 335 {summarily

rejecting Sherman claims after re jecting Clayton claim).

The

majority of courts have since followed Tampa Electric' s dicta.

See,

e.g . ,

Microsoft Corp.,

Hovenkamp,

supra

<][

253 F .3d at 69;

1800c4 n. 67

see also Areeda

{collecting cases).

&

As between

Sections 1 and 2 of the Sherman Act, Section 2 may require less

foreclosure to be substantial than Section 1 .

Microsoft Corp . ,

253 F.3d at 70 {"[A] monopolist's use of exclusive contracts , in

certain circumstances, may give rise to a§ 2 violation even though

the contracts foreclose less than the roughly 40% or 50% share

usually requ ired in order to establish a§ 1 violation.").

Corteva lodges several arguments that it contends establish

per se legality , namely that the agreements are voluntary and cover

nei t her

1 00%

distributors'

of

the

goods .

distributors

nor

It is true t hat

100%

of

participating

courts have factored in

whether customers were "free to walk away from the discounts at

a ny time ."

Concord Boat ,

207

F . 3d at

1059;

see also Allied

Orthopedic, 592 F.3d at 995 (affirming district court that found

t hat agreements were "voluntary and [could] be ended at any time,

and hospi tal s

[were]

t hus free to switch to more competitively

priced generics"); Omega Env't,

duration

and

easy

127 F . 3d at 1163

terminability

of

these

("[T]he short

agreements

negate

60

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 60 of 88

substantially

However,

their

t hese

dispositive,"

potential

cases

as

do

Corteva

not

to

foreclose

treat

t his

suggests.

By

competition.") .

fact

as

contrast,

"entire ly

courts

are

admonished to look to "the practical effect" of exclusive dealing

agreements.

Tampa Elec . , 365 U. S . at 326.

By doing so, courts

have fo und de facto partial exclusive dealing arrangements to be

cognizable violations under antitrust law.

ZF Meritor,

696 F.3d

at 282; Concord Boat, 207 F.3d at 1059 ("[C]laims that allege only

de facto exclusive dealing may be viable.").

Assuming

Defendants'

agreements

are

formally

voluntary,

Plaintiffs have plausibly alleged that the Defendants'

market­

share targets combined with the schedule of payments and threat of

non- price retaliation create de facto exclusivity.

t he

complaint

alleges

that

t he

"complexity,

For example,

uncertainty,

and

timing" of payments "make it less likely t hat a distributor will

lower its prices" and that the t hreat of "canceling distribution

contracts, delaying access to new products , or withholding product

allocation during a supply shortage" instills strict compliance.

(Doc. 149 <J[<J[ 85-88.)

The complaint also alleges t ha t t he loyal ty

discounts

incentive

manage"

create

their

an

generic

for

purchases

distributors

and

"steer"

to

"strictly

customers

toward

loyal ty discount-qualifying products despite consumer demand for

generics.

(Id .

plausible

that

<J[<J[

95,

104 ,

Defendants'

117,

1 47 .)

loyalty

In other words,

discount

programs

it is

are

61

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 61 of 88

"as

effective as express purchase requirements."

See ZF Meritor , 696

F.3d at 283 (recognizing voluntary agreement as de facto exclusive

dealing because

"no

risk averse business would

jeopardize its

relationship with the largest manufacturer of transmissions in the

market" (internal quotation marks omitted)); Dentsply, 399 F . 3d at

194 ("[I]n spite of the legal ease with which the relationship can

be terminated,

the dealers have a strong economic incentive to

continue carrying [the defendant's product]."); McWane , 783 F.3d

at

833-34

(rejecting

argument

that

short-term

and

voluntary

exclusive dealing agreements are " presumptively legal ").

Moreover, the lack of complete exclusivity is not fatal to

Plaintiffs '

claims ,

as

Corteva argues .

It contends

that

the

ability of distributors to purchase some generics and the fact

that

some distributors

(approximately 20%)

creates a presumption of legality.

do

not participate

This position appears at odds

with Tampa Electric, which requires that Plaintiffs demonstrate

the

exclusive

contract's

a

probable

substantial

share

effect

is

of

line

the

to

"foreclose

competition

in

of

commerce

affected ."

365 U.S . at 327 (emphasis added); see also 15 U.S.C.

§ 14 (" . . . where the effect of . . . such condition, agreement,

or understanding may be to substantially lessen competition [. J"

(emphasis added)).

"[ J]ust as 'total foreclosure' is not required

for

deali ng

an

exclusive

arrangement

to

be

unlawful ,

complete exclusivity required with each customer."

nor

is

ZF Meritor ,

62

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 62 of 88

696 F.3d at 283 (analyzing claim under the Sherman Act).

Rather

than treating lack of true exclusivity or voluntariness as legall y

dispositive , the court may weigh the relevance of these facts at

a later stage.

See, e . g . , Concord Boat , 207 F . 3d at 1060 (weighing

lack of true exclusivity on review of summary judgment order) .

Syngenta's

argument

that

dismissal

is

warranted

because

Plaintiffs did not explain why generic competitors do not lower

their price to make their products more profitable to distributors

is similarly unpersuasive at this stage.

(Doc . 1 00 at 35 . )

Even

assuming , without deciding ,

that Plaintiffs bear this burden at

this

plausibly

stage,

they

have

alleged

that

generic

manufacturers' attempts to lower their prices would be futile in

the presence of the

loyalty programs .

This

follows

from the

allegation that distributors would not be willing to accept the

risk of losing all supply from Defendants and becau se Defendants '

forec l osure of the most efficient distribution channel imposes

costs

on

generic

effectiveness . "

This

allegations

manufacturers

market

contention

is

regarding

azoxystrobin

because

program."

(Id.

has

"harmed

the [ ir]

(Doc . 149 <JI 170 , 173 . )

supported

by

Plaintiffs '

manufacturers

of

generics

attempted to enter the market.

Syngenta' s

that

of

<][<JI

and

Manufacturers

metolachlor

"constraints

96-97 , 11 8 , 120.)

that

have

of generics

a llegedl y

imposed by

specific

exited

Syngent a ' s

of

the

loyalty

One generic manufacturer of

63

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 63 of 88

azoxystrobin that sought to mix azoxystrobin with a

fungicide

failed because the distributor feared it could impact its abi li ty

to meet the market-share target.

(Id.

~[<)[

96-97.)

Manufacturers

of generics of mesotrione were also hindered from entering the

market, an issue Plaintiffs allege was exacerbated by Syngenta's

agreement to supply Corteva with mesotrione under the condition

that Corteva's products containing mesotrione be treated neutrally

(Id.

under Syngenta 's Key AI program .

105; Doc. 81

CJ[

CJ[

109.)

Plaintiffs allege that a generic manufacturer of Corteva 's

rimsulfu ron "canceled or deferred entry plans," despite farmer

demand for lower-priced generics of rimsulfuron.

(Doc. 1 49 CJ[ 132.)

According to the complaint, generics of oxamyl found some success

in the market during a "plant outage" at Corteva from 2 015 to 2017 ,

but thereafter under Corteva' s

plummeted ,

particularly

manufacturers

could

lowering prices . "

not

(Id.

CJ[

at

loyalty program,

large

retain

136-38.)

"generic sales

distributors,

distributor

and

business

generic

even

by

One Corteva manager allegedly

said of this pattern , "[O]ur team truly has done an A+ job blocking

generics."

(Id.

<JI

138.)

Finally,

a

generic manufacturer of

acetochlor that was priced "substantially below Corteva 's prices"

allegedly

made

"little

headway"

because

major

distributors

declined to purchase the generic due to Corteva's loyalty program.

(Id.

CJ[

14 8 . )

At this preliminary stage,

t he court must accept

these plausible factual allegations as true and draw all reasonable

64

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 64 of 88

inferences in Plaintiffs'

favor.

Through this lens,

Defendants

have not demonstrated that the widespread failure of generics to

enter the market is due to competition on the merits rather than

plausibly anticompetitive conduct by Defendants.

Finally,

Plaintiffs have plausibly alleged anticompetitive

conduct and injury .

In Kolon, the Fourth Circuit, in reviewing a

Sherman Act§ 2 claim on motion to dismiss, held that an allegation

of dominant market share and exclusionary conduct was sufficient

at the pleading stage.

637 F.3d at 452 (citing Advanced Health-

Care Servs., Inc. v. Radford Cmty. Hosp., 910 F.2d 139 , 147 (4th

Cir . 1990)).

While the court also held that pleading a percentage

of market foreclosure is not necessary, Plaintiffs have pleaded a

foreclosure

market."

of

"approximately

(Doc. 81

70%

or more

of

each

applicable

171); see Microsoft, 253 F . 3d at 70 (finding

~

substantial 40 - 50% of market foreclosure under Sherman Act § 2

claim) .

Under

all

of

the

antitrust

statutes,

Plaintiffs'

allegations of substantial foreclosure are plausible and,

at a

minimum, "turn[] on a factual dispute ill suited for the pleadings

stage."

F.T.C .

(D.D . C . 2020) .

argument

v.

Surescripts,

LLC,

424

F.

Supp.

3d 92,

104

Moreover, for the reasons noted above, Syngenta's

that

Plaintiffs

have

not

alleged

anticompetitive

conduct because they have not alleged predatory pricing - likewi se

fails.

To t he extent these arguments apply under the rule of

reason, they appear to speak to "whether an otherwise unacceptable

65

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 65 of 88

level

of

market

efficiencies. "

foreclosure

Chuck' s Feed,

is

justified

by

procompetitive

81 0 F.2d at 1294 ;

(Doc . 100 at 34

(framing price reduc t ions as procompetitive) . )

Simply put ,

the

court is not equipped at this stage and on this record to weigh

the

merits

of

this

procompetitive

justification

against

the

plausible allegations of market foreclosure .

Pl aintiffs have a l so sufficiently al l eged antitrust injury.

They claim harm to farmers , growers,

and generic manufacturers,

and that Defendants ' conduct "may substantially lessen competition

or

tend

to

[m]arkets. "

create

or

maintain

(Doc. 1 49 <JI<JI 164 - 66 . )

monopolies

in

the

[r]elevant

Specifically, Plaintiffs a llege

that generic manufacturers have been substantially foreclosed from

the most efficient channel of distribution (id. 11 170 - 71); that

the structure of the payments over an extended period of time, and

across multiple crop- protection produc t s containing the same AI ,

make it l ess likely that discounts will pass on to end-consumers

(id. 11 173-75) ; that distributors have "omitted generic products

from their price lists ,

refused customer reques t s for generics ,

declined generic companies '

offers to supply, and systematical ly

steered retailers and farmers toward branded products" (id . <JI 177);

that the l oyal ty programs have caused generics to exi t

or never

enter the market (id . <JI1 182-85); and that the loyalty programs

have

stunted innovation

alleges that Defendants '

(id .

11

186- 89) .

The

complain t

also

internal analyses acknowledge that the

66

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 66 of 88

loyalty

programs

lead

to

supracompetitive

prices

for

end-

(Id. ~i 1 94-200.)

consumers.

In sum,

neither

are

depends

on

Defendan t s '

contention that their loyalty programs

anticompetitive

further

factual

nor

cause

anticompetitive

development .

At

this

injury

stage ,

the

complaint plausibly alleges both. 10

3.

Claims Against Syngenta Corporation and Syngenta

Crop Protection AG

Syngenta

cognizably

argues

connect

that

Syngenta

"Plaintiffs '

a l legations

Corporation

or

do

not

Syngenta

Crop

(Doc .

100 at

Protection AG to the challenged rebate program ."

44 . )

two

Consequently, Syngenta contends ,

entities

Corporation ,

should

Syngent a

be

dismissed .

the claims a gainst those

(Id . )

maintains t hat more

is

As

to

Syngenta

requ ired t han an

allegation that Syngenta is a "single enterprise " and that one

person is the president of both Syngenta Corporation and Syngenta

Crop Protection, LLC .

(Id . at 44-45.)

And as to Syngenta Crop

Protection AG, Syngenta argues that Plaintiffs ' "vague al l egations

of high-level oversight and strategic guidance" are insufficient

10

Plaint iff FTC argues that i t s sect ion 5 claim is a "standalone" claim .

In part icular, the FTC argues that the price- cost

(Doc . 150 at 45.)

test should not apply to i t s section 5 c l aim, regardless of how the court

rules on t he Sherman Act and Cl ayt on Act claims.

(Id. a t 47.) Because

Plaint iffs plausibly allege violat ions of t he Sherman Act and Clayt on

Act , the court will deny Defendants ' motion to dismiss Plaint iff FTC ' s

section 5 c l aim for the same reasons as for the Sherman Act and Cl ayton

Act clai ms . Therefore , whether or not the court may f i nd i t necessar y

to pa r se distinct ions bet ween the statu tes a t a l a t er s t age in this

action, i t need not do so now .

67

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 67 of 88

in light of Plaintiffs '

"conce[ssion] that the global parent is

not responsibl e for ' impl ementation ' of post-patent strategies in

individual countries . "

Plaintiffs

Corporation ' s

(Id. at 45.)

respond

shared

that

senior

their

allegations

leadership

with

of

Syngenta

Syngenta

Crop

Protection, LLC, and management of contacts with Corteva regarding

the mesotrione and metolachlor supply agreements suffice to state

claims against Syngenta Corporation .

at 65-66 . )

(Doc. 150 at 65-66 ; Doc. 11 2

Further, Plaintiffs contend that they have stated a

claim against Syngenta Crop Protection AG because it "directs and

oversees" the LLC ' s post-patent strategy, "reviews , modifies, and

approves

Syngenta' s

U.S.

budget,

which includes

sales

targets

based on Syngenta' s loyalty program, " and was " directly involved

in

the

negotiation

Corteva .

of"

the

mesotrione

supply

agreement

with

(Doc. 150 at 66.)

To be sure, Plaintiffs do not a llege a conspiracy between the

Syngenta entities.

Parents and subsidiaries, as well as sister

subsidiaries , are "incapable" of conspiring with one another under

Sections 1 and 2 of the Sherman Act and Section 3 of the Clayton

Act.

Copperweld Corp . v . Independence Tube Corp . ,

768 , 777 (1984)

(parent-subsidiary under Sherman Section 1); Lenox

MacLaren Surgical Corp. v. Medtronic,

(10th Cir .

2017)

("[S] ubsidiaries

under

of the

Sherman Act. .

§

1

467 U. S . 752,

Inc.,

are

84 7 F. 3d 1221,

1234

incapable

of conspiring

[W] e

conclude

also

that

68

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 68 of 88

Copperweld' s

§ 2.");

reasoning with respect to

Advanced

Health-Care

1

§

Servs.,

910

applies equally to

F.2d

at

1 46,

152

(extending Copperweld to sister subsidiaries under Sherman Section

1 and Clayton Section 3).

Instead, "[t]he coordinated activity of

a parent and its wholly owned subsidiary must be viewed as that of

a single enterprise[ . ] "

Copperweld, 467 U.S. at 771.

In Lenox MacLaren, the Tenth Circuit affirmed on other grounds

but wrote at length on the district court's error in treating each

corporate affiliate as a separate entity rather than a

enterprise."

847

F.3d at

1230-39.

The

court

"single

observed that

requiring each corporate affiliate to independently satisfy every

element of an antitrust violation "would be difficult to justify"

because the Supreme Court and other courts have sealed off access

to the claim of conspiracy between corporate affiliates .

1236 (citing Copperweld, 467 U. S . at 776- 77) .

Id . at

Moreover, the court

reasoned that Copperweld must foreclose sophisticated corporations

from

"spread[ing]

its

anticompetitive

scheme

over

multiple

subsidiaries , such that no one entity met all the requirements for

individual antitrust liability."

Id.

But the Lenox MacLaren court

was careful to cabin the reach of the single-enterprise theory by

emphasizing Copperweld' s restriction of intra-enterprise liability

only

to

"coordinated

activity"

of

affiliates.

Id.

at

1237

(emphasis in original).

Indeed,

"[a] nti trust

law doesn't

recognize guilt

by mere

69

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 69 of 88

association ,

imputing

corporate

liability

to

any

affiliated

company unlucky enough to be a bystander to its sister company ' s

alleged misdeeds."

SD3, LLC v. Black & Decker (U.S . ) Inc . ,

F.3d 412, 422 (4th Cir. 2015).

801

"[I]n the antitrust context, courts

have held that absent allegations of anticompetitive conduct by

the parent, there is no basis for holding a parent liable for the

alleged antitrust violation of its subsidiary."

Arnold Chevrolet

LLC v.

(E.D.N.Y.

Tribune Co.,

418 F.

Supp .

2d 172,

178

2006)

(citing Invamed. Inc. v. Barr. Lab'ys, Inc., 22 F. Supp. 2d 210,

219 (S.D.N.Y. 1998); see also United States v. Bestfoods, 524 U.S.

51, 61 (1998)

("It is a general principle of corporate law deeply

ingrained

our

in

economic

and

legal

systems

that

a

parent

corporation . . . is not liable for the acts of its subsidiaries."

(internal

quotation marks

omitted)).

Accordingly,

claims may

properly be dismissed against parent corporations where "at least

as to them,

the 'complaint was vague, never explained its case,

and lumped [them] together without sufficient detail.'"

Decker,

801 F . 3d at 423

F.3d 951 ,

958

(7th Cir.

Black &

(quoting Bates v . City of Chicago,

2013)).

Here ,

726

the complaint defines

"Syngenta" as "Syngenta Crop Protection AG, Syngenta Corporation,

and

Syngenta

Notwithstanding

Crop

Protection,

LLC."

(Doc.

149

<JI

this

definition,

Plaintiffs

still

must

allege

1.)

sufficient independent but coordinated activity for each named

corporate affiliate.

Black & Decker, 801 F . 3d at 422 .

70

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 70 of 88

While the

adopting

Lenox MacLaren court ultimately refrained from

either

party ' s

proposed

definition

activity, " the court considered as tests

(1)

of

"coordinated

"[w] hen the parent

controls, dictates or encourages the subsidiary's anticompetitive

conduct"; and (2) "that each defendant must have played a

' role'

-

of

or

'participated'

in

enterprise as a whole."

Co. v. Molychem,

2005)).

the

anticompetitive

conduct

the

Id. at 1237-38 (quoting Climax Molybdenum

L.L . C.,

414 F .

Supp.

2d 1007,

1012

(D.

Colo.

Plaintiffs appear to endorse the "controls, dictates, or

encourages" test.

(Doc. 150 at 65-66 (citing Intellectual Ventures

I LLC v. Cap. One Fin. Corp., Case No. 1 4-1 11 , 2016 WL 1 60263, at

*5

(D . Md.

2015) ;

Channel Commc'ns ,

2004)).)

Nobody in Particular Presents,

Inc., 311 F. Supp. 2d 1048, 1068- 70

Syngenta

articulation

of

Inc. v . Clear

does

the

not

take

a

standard

and

relied

questioned about it at the hearing.

position

on

on

its

(D. Colo.

the

proper

briefs

when

(See Doc. 1 00 at 44-45; Doc.

130 at 23; Doc. 157 at 98:18-23 . )

At least at the time of the complaint ,

the same individual

served as t he president of both Syngenta Corporation and Syngenta

Crop Protection, LLC .

t hat

(Doc . 149 'J[ 35 . )

Syngenta Crop Protection AG has

Further, Plaintiffs allege

"directed,

approved Syngenta 's sales and marketing strategy,

loyalty program."

(Id .

'J[

36.)

AG allegedly has " reviewed ,

overseen ,

and

including its

Moreover, Syngenta Crop Protection

modified,

and approved" Syngenta' s

71

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 71 of 88

U.S. budget , which includes the sales targets associated with Key

AI, and provides "generic defense" strategy to be "tailored for

(Doc. 81 i 36 (quoting Syngenta

implementation in each count ry ."

Crop

Protection

Finally,

AG ' s

Plaintiffs

global

allege

post-patent

that

strategy

executives

of

handbook).)

Syngenta

Crop

Protection AG were "directly involved in the negotiation" of the

Syngenta-Corteva mesotrione supply agreement ,

t hat

Syngenta Crop

Protection AG is t he Syngenta entity that signed the agreement,

and that

a

Syngenta Corporation executive

"manages

contacts with Corteva regarding the agreement."

Based on t hese allegations,

that

the

complaint

activity. "

As a

fails

result ,

to

Syngenta' s

(Doc. 149 1 111.)

Syngenta has not demonstrated

plausibly

allege

"coordinated

the motion to dismiss

Syngenta Crop

Protection AG and Syngenta Corporation will be denied.

4.

Article II Challenge to FTC Authority

Defendant

Corteva

argues

that

the

"FTC' s

claims

must be

dismissed because the FTC lacks the constitutional authority to

bring these claims . "

(Doc . 95 at 30 . )

Plaintiff FTC ' s alleged

authori ty to bring this lawsuit arises under Section 13(b) of the

FTC Act,

15 U. S . C.

§

53 (b) .

(Doc . 14 9 i

2. )

Corteva contends

t hat Congress ' grant of authority to the FTC to pursue relief under

t hese provisions amounts to a grant of executive law-enforcement

power

that

is

unconstitutional

because

removable at will by the President."

its

(Id .

" members

are

not

(citing Humphrey's

72

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 72 of 88

Executor v. United States, 295 U.S. 602

(1935); Seila Law LLC v.

Consumer Fin . Protection Bureau, 140 S. Ct. 2183 (2020) .)

Corteva

maintains that because executive agencies must be subject to the

President's removal power, the suit before this court cannot go

forward .

(Id . at 32.)

The FTC responds that Corteva' s Article II

challenge is untimely because it was not raised in its motion to

dismiss the original complaint .

(Doc . 15 0 at 61 . )

Moreover, in

t he FTC ' s view, Corteva "grossly misinterpret[s] binding Supreme

Court precedent" by misstating the FTC' s historical powers and

ignoring

features

agencies.

(Id.

of

the

FTC

that

distinguish

it

from

other

(quoting Fed. Trade Comm' n v. Roomster Corp . , No.

22 Civ . 7389, 2023 WL 1438718, at *8

(S . D.N . Y. Feb. 1, 2023)) . )

Finally,

if Corteva were

the

FTC

contends

that even

dismissal of the action would be the improper remedy .

correct,

(Id . )

In

reply , Corteva contends that its claim is not waivable because it

is akin to a subject matter jurisdiction challenge.

(Doc. 1 33 at

17-18.)

As to timeliness,

Procedure 12 (g) (1).

the FTC cites to Federal Rule of Civil

(Doc.

150 at 61.)

But this rule does not

support the FTC' s position that Corteva waived its argument by

omitting it in an earlier motion to dismiss.

Rule 12 (g) (1) applies

to joinder of motions and is t hus inapplicable here.

In any event,

the Federal Rules do not otherwise support the FTC' s position.

Rule 12(h) (1) provides that a party waives any de fense available

73

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 73 of 88

under Rules 12(b) (2)

through (5) if the defense was available to

the party at the time of an earlier motion.

12 (h) (1)

Fed .

R.

Civ.

P.

(providing for waiver through omission as described in

Rule 12(g)(2) 11 ).

Notably,

these include motions

to challenge

personal jurisdiction , venue , and service of process , not a motion

to dismiss for failure to state a claim upon which relief can be

granted

(Rule 12 (b) (6))

(Rule 12 (b) (1)).

or lack of subject matter jurisdiction

Fed. R. Civ. P. 12 (h) (1) and (3).

In fact, the

1966 Advisory Committee note to Rule 12(h) states that , "while the

defenses specified in subdivision (h) (1) are subject to waiver as

t here provided, the more substantial defense[] of failure to state

a

claim upon which relief can be granted

[is]

expressly

preserved against waiver by amended subdivisi on (h) (2) and (3) . u

Fed. R. Civ. P. 12 (h) advisory comm. note (1 966 amend.)

(emphasis

added) .

Similarly, the FTC 's citation to Rowley v. McMillan, 502 F.2d

1326

(4th

Cir .

1974)

is

misguided .

In

Rowley ,

the

court

interpreted Rule 12(g) to mean t hat "an amendment to the pleadings

permits

the

responding

pleader

to

assert

only

such

of

those

defenses which may be presented in a motion under Rule 12 as were

11

Rule 12 (g) (2) provides:

Except as provided in Rule 12(h) (2) or (3), a party that makes

a moti on under this rule must not make another motion under

this rule raising a defense or objection that was available

to the party but omitted from its earlier motion .

74

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 74 of 88

not available at the time of his response to the initial pleading.n

Id. at 1333.

Despite this broad language covering "defenses,n the

issue before the court was a waiver of a personal jurisdiction

defense

pursuant

12(h) (l)'s

to

strict

Rule

waiver

12 (b) (2),

rules.

which

Id .

is

at

covered

1333.

by

Rule

Cases

that

approvingly cite Rowley deal similarly with the 12(b) (2)

( 5)

defenses that Rule 12 (h) ( 1)

covers.

See,

e . g. ,

through

Hand Held

Prods., Inc . v . Code Corp . , 265 F. Supp. 3d 640, 643 (D.S.C. 20 1 7)

(challenging venue);

Maxtena,

Inc .

v.

2012 WL 113386 (D. Md. Jan. 12, 2012)

Marks,

to

raise

same

"little would be

constituti onal

(challenging service

argument

gained by preventing

& Proc.

§ 1388

determination

of

[12(b) (6)

Corteva

argues

analogy

is

arguments]

that

its

both unnecessary to

save

20 1 2)

("If

a

plaintiff

colorable claim 'arising under'

to

be

constitutional

its

argument

in any event .

Holloway v. Pagan River Dockside Seafood I nc.,

Cir.

is

(2023)

subject matter jurisdiction,

appears to be an improper characterization

(4th

so

Prac .

("[E]arly

is akin to non - waivable

answer,

under Rule []

Fed .

While

its

defense

Wright and Miller ,

encouraged.").

in

a

12 (b) (6)."

such an

11-0945,

Moreover, Rule 12(h) (2) clearly author i zes Corteva

this

challenge

No.

(same); Lederman v. United

States, 131 F. Supp. 2d 46, 58 (D.D.C. 2001)

of process).

Civ .

669 F.3d 448,

invoking§ 1331 pleads

and

See

453

a

the Constitution or laws of the

United States, he i nvokes federal subject matter jurisdiction, and

75

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 75 of 88

deficiencies

of

the

claim

should

be

addressed

mechanisms provided by the federal rules."

marks and citations omitted)) .

by

the

other

(internal quotation

This is a long way of explaining

that the court must turn to the merits of Corteva's constitutional

challenge.

The power to enforce the law is vested in the President of

the United States.

person

could

U.S. Const. art. II, § 1.

fulfill

that

responsibility

"Because no single

alone,

the

Framers

expected that the President would rely on subordinate officers for

assistance. "

Seila Law ,

140 S. Ct.

at 2191.

" [A] s

a general

matter," t he Constitution gives the President the power to remove

subordinate officers so that the President can be held "fully

accountable

for

discharging

Enterprise Fund v.

477 ,

514

his

own

responsibilities."

Pub . Co. Accounting Oversight Bd.,

(2010) .

There

are

"only

two

exceptions"

President's otherwise unrestricted removal power.

S. Ct. at 2192 .

Free

56 1 U.S.

to

the

Seila Law, 140

First , Congress may create "expert agencies led

by a group of principal officers removable by the President only

for good cause ."

(emphasis

Id.

(citing Humphrey's Executor , 295 U.S. 602)

in original) .

Second,

Congress may provide "tenure

protections to certain inferior officers with narrowly defined

duties."

(1886);

Id.

(citing United States v.

Morrison v.

original).

Olson,

487

U. S.

654

Perkins,

116 U.S.

483

(1988))

(emphasis

in

The parties agree that this case implicates only the

76

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 76 of 88

first exception.

Under

the

"inefficiency,

U.S.C . § 41.

(Doc. 95 at 31 ; Doc. 150 at 61.)

FTC Act,

commissioners

neglect of duty ,

are

removable

only

for

or malfeasance in office . "

15

Five members sit on the Commission and are appointed

Id .

by the President and confirmed by the U. S. Senate .

The FTC

Act includes a "separability clause" that states that the other

provisions of the FTC Act "shall not be affected" by a court's

holding that finds any provision invalid.

15 U. S . C. § 57 .

The constitutionality of the FTC commissioner's

for-cause

protection was first addressed in Humphrey' s Executor,

295 U.S.

602

(1935).

In 1933, President Frankl in Delano Roosevelt sought

the removal of Commissioner William E . Humphrey, who was appointed

by President Herbert Hoover.

Id. at 618.

After Humphrey rebuffed

his resignation request, President Roosevelt wrote him : "Effective

as

of

this

Commissioner

date

of

you

hereby

Federal

removed

the

the

Supreme

the

the

FTC

is

I d.

of

Reviewing the constitutionality of the President's action,

that

Commission."

office

61 9.

observed

Trade

from

at

Court

the

are

"charged

with

enforcement of no policy except the policy of the law," adding

that

" [i] ts

duties

are

neither

political

nor

executive,

predominantly quasi judicial and quasi legislative."

but

Id. at 624.

The court reasoned that the authority of Congress to create quasi

legislative or quasi judicial agencies "cannot well be doubted"

and includes the power to "forbid their removal except for cause . "

77

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 77 of 88

I d. at 629 .

In supporting Congress ' authority to restrict removal,

the Court observed that its ho l ding would not offend the separation

of powers because the FTC was creat ed by Congress "as a means of

carrying into operation legislative and judicial powers " and was

"wholly disconn ected from the executive department."

The

Supreme

Court

Humphrey ' s Executor.

has

since

q uestioned

the

Id. at 630.

holding

of

See , e . g. , Seila Law, 140 S. Ct . at 2198 n.2

("The Court ' s conclusion [in Humphrey ' s Executor] that the FTC did

not exercise executive power has not withstood the test of time . ");

Morrison , 487 U. S . at 690 n.28 ( "[ I]t is hard to dispute that the

powers of the FTC at t h e time of Humphrey ' s Executor wou l d at the

present time be considered 'executive ,' at least to some degree . ") .

Nevertheless , the Court has declined to overrule this " entrenched

Supreme Court preceden t , protected by stare decisis . "

Cnty . ,

645

F . 3d

428 ,

446

(D . C.

Cir.

2011)

In re Aiken

(Kavanaugh,

J .,

concurring); see a l so Coll ins v. Ye llen, 1 41 S. Ct . 176 1 , 1 786-87

(202 1 )

(citing

Humphrey ' s

Executor

as

a

counter-analogy

and

striking down removal restriction as violation of separation of

powers) .

Congress added the FTC' s authority to file suit under section

13(b) in 1973 - decades after the Court decided Humphrey ' s Executor

i n 1935.

See Pub. L . No.

93- 153 ,

§

408 ,

87 Stat.

592

(1973).

While Corteva is correct that the FTC' s authority u nder section

13(b) is executive in nature , that is about where the merit of its

78

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 78 of 88

constitutional challenge ends.

First,

Corteva effectively asks

this court to overrule Supreme Court precedent .

a lower court is clear :

But the role of

"If a precedent of [the Supreme] Court

has d irect application in a case, yet appears to rest on reasons

rejected in some other line of decisions, the [lower court] should

follow the case which directly controls, leaving to [the Supreme]

Court the prerogative of overruling its own decisions."

v . Felton, 52 1 U. S . 203, 237

v.

Shearson/Am.

Humphrey' s

Express,

Executor

(1 997)

Inc. ,

directly

Agostini

(quoting Rodriguez de Quijas

490

U. S.

addresses

477,

whether

485

(1989)) .

Congress

may

restrict the removal power of FTC commissioners , so the court could

stop its analysis here. 12

Second, even were the court to accept Corteva's position that

t he

FTC

commissioners

must

be

removable,

Corteva's

relief - dismissal of the suit - would be inappropriate .

requested

Corteva

12

Even so, there is hardly a consensus, as Corteva contends, that

Humphrey's Execu tor is wrong in light of the FTC' s greater scope of

authority since the case was decided. See, e . g., Seila Law , 140 S. Ct.

at 2198 ("Rightly or wrongly, the Court viewed the FTC (as it existed

in 1935) as exercising ' no part of the executive power.'" (quoting

Humphrey's Executor, 295 U.S. at 628)); id. at 2200 n.4 ("Perhaps the

FTC possessed broader rulemaking , enforcement, and adjudicatory powers

than the Humphrey's Court appreciated.

Perhaps not.

Either way, what

matters is t he set of powers the Court considered as the basis for its

decision, not any latent powers that the agency may have had not alluded

to by the Court."); id. a t 2239 n. 10 (Kagan, J. , concurring in the

judgment with respect to severability and dissenting in part) (describing

the FTC's authority in 1935 as

including the power t o "run

investigations,

bring

administrative

charges,

and

conduct

adjudications"). Simply put, this court is not at liberty t o "read the

tea l e aves" of the Supreme Court with respect to settled precedent .

Stewart v . Justice, 518 F . Supp . 3d 911, 917 (S . D.W . Va . 2021).

79

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 79 of 88

contends that the FTC cannot "both enjoy its removal protections

as

upheld

in

Humphrey's

Executor

and

e xercise

the

'quintessentially executive' powers granted to it by Congress in

1973. "

(Doc . 95 at 32

(citing Seila Law,

140 S. Ct . at 2200) . )

But no case cited by Corteva suggests that the appropriate remedy

would be to excise the FTC ' s executive power .

To the contrary,

the Supreme Court ' s cases on removal suggest the exact opposite.

In Seila Law , the Court held the CFPB director must be removab l e,

severed the provision restricting removal, and declined to strike

down

the

authority.

Consu mer

Financial

140 S . Ct. at 2199.

Protection

Bureau ' s

enforcement

In Free Enterprise Fund, the Court

held that the removal restrictions of the Public Company Accounting

Oversight

Board

violated

the

separation

of

powers ,

but

it

explicitly upheld the board's regulatory authority .

561 U. S . at

508 - 09 .

the

And

in

Collins ,

the

Court

struck

down

removal

protections for the Federal Housing Finance Agency director , but

it nevertheless stated that "there is no basis for concluding that

any

head

of

the

FHFA

lacked the

functions of the office . "

Congress

oversteps

removal power ,

its

141 S.

authority

authority to

carry o u t

Ct. at 1788.

Thus ,

to

restrict

the

even if

President's

a principal officer may still " undertake the

responsibi l ities of his office."

the

[]

Id. at 1 788 n.23.

In s um, Cort eva' s position tha t section 13(b) was void when

enacted is u npersuasive, and even if it were not , dismissal would

80

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 80 of 88

not be the proper remedy.

As a result, Corteva ' s motion to dismiss

based on its constitutional challenge will be denied.

5.

State Law Claims

Defendants argue that all of the state Plaintiffs'

(Doc.

should be dismissed .

Defendants

contend

that

95 at 34; Doc. 100 at 43.)

each

state's

(except

claims

First,

Tennessee ' s

and

Wisconsin's)

antitrust laws are "harmonized -

by statute or by

common law -

with t he federal antitrust laws."

(Doc . 95 at 34;

Doc. 100 at 43 . )

Consequently, Defendants maintain that the state

Plaintiffs' claims should be dismissed on the same grounds as the

federal claims.

(Doc. 95 at 34; Doc. 100 at 43.)

With respect to

Tennessee and Wisconsin, Corteva argues that the complaint fails

to allege "substantial effects that were felt in each respective

state."

(Doc . 95 at 35.)

Second, Corteva contends that Texas and

Indiana cannot recover civil damages under state antitrust laws

because t hose states are "prevent [ed]

from bringing damages

claims on behalf of end-consumers."

(Doc . 95 at 34-35 . )

Defendants

Indiana ,

argue

t hat

California,

and

Iowa

Third,

fail

to

adequate ly allege violations of the ir state unfair competition and

consumer fraud laws.

In response,

(Doc. 95 at 36; Doc . 100 at 43-44 . )

Plaintiffs first argue that state and federal

laws are not "automatically harmonized,

state."

(Doc .

150

at

68.)

As

to

and vary from state to

Tennessee

and Wisconsin,

Plaintiffs contend, they have met the substantial effects burden,

81

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 81 of 88

which they characterize as "low."

(Doc. 150 at 71-72.)

Second,

Plaintiffs argue that Texas and Indiana are not seeking damages on

behalf of "end-consumers," and , in any event , these states are not

barred from recovering civil penalties.

Third, Plaintiffs contend

that the California unfair competition claim and Indiana and Iowa

consumer protection claims are sufficiently pleaded .

As to the state antitrust laws that Defendants contend are

h armonized with federal l aw,

in light of the court ' s rulings on

the federal antitrust claims,

Defendants have not demonstrated

that

dismissed.

these

Wisconsin ,

claims

should

Defendants '

be

As

to

arguments similarly fail.

Tennessee

and

Tennessee and

Wisconsin courts require plaintiffs to allege that a defendant's

anticompetitive conduct had a "substantial effect" on intrastate

commerce."

See Meyers v . Bayer AG, Bayer Corp ., 735 N . W. 2d 448 ,

4 61 (Wis. 2 0 07)

( " [A ] complaint under the Wisconsin Anti trust Act

. is sufficient if it a lleges [anticompetitive conduct] that

substantially affected the people of Wisconsin and had impacts in

[Wisconsin] .");

Freeman

S.W . 3d 512,

(Tenn . 2005)

alleged

523

anticompetitive

Indus. ,

LLC v.

Eas t man Chem.

Co .,

172

("[C]ourts must decide whether the

conduct

affects

commerce to a substantial degree ." ) .

Tennessee

trade

or

"The [substantial effects]

test is pragmatic, turning on the particul ar facts of the case."

Freeman Indus . 172 S . W. 3d at 523 .

Under Wisconsin law, a plaintiff

need not allege that the impact of the conduct is "dist inguishable

82

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 82 of 88

from or disproportionate to its impacts on other states . "

735 N.W.2d at 320. 13

Meyers,

Under Tennessee law, a plaintiff need not

allege that the anticompetitive conduct "threaten[s] the demise of

Tennessee business

or affect [s]

market price

to

substantially

affect intrastate commerce," but a plaintiff must show more than

Freeman Indus . , 172

a "bare allegation" of substantial effects.

S.W.3d

at

524

(finding

allegation

insufficient

where

lone

plaintiff with ties to Tenne ssee did not allege that he purchased

goods from defendant).

Corteva claims that these Plaintiffs did no more than recite

each

state' s

legal

requirement

(Doc.

95

35-36.)

But

at

incorporated,

Tennessee's

by re - alleging,

complaint,

Tennessee

alleged

protection

products

at

individual

customers,

substantial

and

effects.

Wisconsin's

claims

every preceding allegation in the

that

issue

and

regarding

to

Defendants

sold

Tennessee

businesses

Wisconsin

al l eged

the

cropand

"substantial

foreclosure of generic competitors" within the state and that "many

hundreds of farmers" in the state have purchased crop- protection

products at supracompetitive prices due to the loyalty programs.

(Doc . 149 ~~ 253-54, 272, 274-75 . )

Accepting these facts as true ,

as the court must at this stage, Tennessee and Wisconsin plausibly

13

While the Meyers court announced this rule in light of its self­

described "liberal pleadings standard," Meyers , 735 N. W. 3d at 320 ,

Defendants have not provided any authority to suggest that a different

result should obtain under the federal rules .

83

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 83 of 88

allege substantial effects.

As to Texas ' s and Indiana's claims, Corteva argues that the

indirect p u rchaser rule bars Texas and Indiana from recovering on

behalf of end-consumers .

The indirect purchaser rule restricts

indirect purchasers from recovering compensatory damages ,

in

limited

circumstances

not

relevant

here .

See

except

Dickson

v.

Microsoft Corp ., 309 F . 3d 193 , 214 (4th Cir. 2002) (citing Il l inois

Brick Co . v.

Illinois,

43 1 U. S.

720,

730 - 33

(1 977 ) ) .

However,

Defendants have not demonstrated that Illinois Brick extends to a

state seeking civil penalties.

See , e.g., Fed. Trade Comm'n v.

Mylan Lab ' ys, Inc., 62 F . Supp. 2d 25 , 46 (D.D.C. 1999) (dismissing

state

claims

for

actual

damages

under

Illinois

Brick

but

maintaining claims for civil penalties) ; Apple Inc. v. Pepper , 139

S.

Ct .

15 1 4 ,

1520 n. 1

("Illinois Brick held that

the direct­

purchaser requirement applies to claims for damages . "

added) ) .

Additionally,

(emphasis

the cases that Corteva cites to support

Texas's and Indiana ' s prohibitions on parens patriae suits do not

s u pport extending Illinois Brick to those state's civil penalties

provisions.

596

See Berghausen v. Microsoft Corp . ,

(Ind . Ct . App.

2 002 )

765 N.E.2d 592,

(acknowledging application of Illinois

Brick to Indiana antitrust law but not discussing civil pena l ties

or suits brough t by the state); Abbott Lab ' ys , I nc. v . Segura, 907

S . W.2d 503 , 503- 04 (Tex. 1995)

(barring parens patriae suit under

state DTPA to recover damages, but not civil penalties , on behalf

84

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 84 of 88

of consumers).

Moreover, while all Plaintiffs identify harm to

end-consumers,

(Doc. 149

<JI

166),

the claims for civil penalties

are not damages compensation for consumers .

264.)

(Doc .

149 11 228 ,

Accordingly, on this record Texas's and India na ' s requests

for civil penalties survive t he motion to dismiss .

As t o California's unfair competition claim, Corteva argues

t hat

because Plaintiffs' antitrust claim should fail,

t he California unfair competition claim.

so should

The California Un fair

Competition Law covers conduct that "violates the policy or spirit"

of the antitrust laws "or otherwise significantly threatens or

harms competition."

Cel-Tech Commc ' ns, Inc. v . L.A. Cellular Tel.

Co., 20 Cal . 4th 163, 180-87 (1999) .

Because California re-alleged

and incorporated by reference all allegations in the complaint,

(Doc. 149 1 212), the court will deny the motion to dismiss on the

same bases that it has denied Defendants' motions with respect to

t he federal antitrust claims.

As to Indiana's consumer protection claim, Defendants argue

that Indiana did not specify an "incurable deceptive act" which,

in Corteva's view, must be alleged with particularity "as part of

a scheme, artifice, or device with intent to defraud or mislead . "

(Doc. 95 at 36 (citing Fed. R. Civ. P. 9(b); Thunander v. Uponor,

Inc., 887 F. Supp. 2d 850, 873 (D. Minn. 2012); Ind. Code§ 24-50 . 5 - 2(a) (8)) .)

Syngenta also argues that the theory of wrongdoing

is not illegal for the same reasons it offered to dismiss the

85

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 85 of 88

federal antitrust claims , which the court has now rejected at this

stage.

(Doc .

100 at

43 . )

Indiana responds that reliance on

Thunander is improper because the case predates an amendment to

Indiana's consumer protection law that expanded the scope of the

statute covering "deceptive" acts to also preclude "unfair" acts.

(Doc . 15O at 7 O. )

In Indiana 's view,

this amendment likens its

law to the California unfair competition law .

Lastly,

Indiana maintains t h at it does not need to show an "incurab le

deceptive act" because only private plaintiffs are subject to this

requ irement , not the state attorney general.

In 2014, Indiana amended its consumer protection statute to

prohibit

"an

unfair ,

abusive,

or

deceptive

act ,

omission,

practice in connection with a consumer transaction ."

or

2014 Ind.

Acts 736 , Ind . P.L . 65-20 14, § 7 (codified as amended at Ind. Code

§ 24 - 5 - 0.5- 3(a)).

Under section 4(a), "a person" may file suit to

recover damages for an "uncured or incurabl e deceptive act . "

Code§ 24-5-0 . 5-4(a) .

Ind.

An "incurable deceptive act" is one that is

"done by a supplier as part of a scheme, artifice, or device with

intent to defraud or mislead ."

Ind .

Code § 24-5-0.5-2 (a) (8).

Under sections 4(c ) and (g), the state attorney general may file

suit for an injunction and civil penal ties against "a deceptive

act."

Ind. Code§ 24-5-0.5-4(c) , 4(g).

First , Corteva has not provided any authority to support the

contention that "unfair " or "abusive" should be read more narrowly

86

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 86 of 88

than under the FTC Act, so the court will not read it so at this

time.

Second,

4 (c),

it appears that Indiana is correct that section

which grants authority to the state attorney general to

enjoin "a deceptive act," does not impose a requirement to show

that the deceptive act is "uncured" or "incurable."

the private party provision does.

4(a)

By contrast,

Compare Ind. Code. § 24-5-0.5-

("A person relying upon an uncured or incurable deceptive act

may bring an action . . . . "

0 . 5-4(c)

(emphasis added)), with id. § 24-5-

("The attorney general may bring an action to enjoin a

,,

deceptive act

(emphasis

added)) .

If this

additional

requirement were read into section 4(c), t he claim would apparently

sound in fraud and require pleading with particularity.

Code § 24 - 5-0. 5 - 2 (a) (8)

See Ind.

("act done . . . with intent to defraud or

mislead . "); Fed . R. Civ. P. 9(b).

While it appears that Indiana

has

this

the

better

of

the

argument,

question

of

statutory

interpretation is inadequately briefed to facilitate a definitive

resolution at t h is

stage,

so the court will

simply hold that

Defendants have not demonstrated for t he purposes of this motion

that Indiana has not stated a claim for relief.

Finally,

as

to

Iowa 's

consumer protection claim,

Corteva

argues that Iowa did not allege a "misrepresentation of material

fact . "

(Doc. 95 at 37 (citing Cota v. Ralph Lauren Corp., No. 21-

C-1089, 2022 WL 1597631, at *3 (E.D. Wis. May 19, 2022) .)

Syngenta

agrees

"unfair

and

adds

that

Iowa

also

did

not

allege

an

87

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 87 of 88

practic [e]."

(Doc. 100 at 44 (citing Iowa Code§ 714 . 16 .)

Iowa

argues that the Iowa consumer protection l aw covers both deceptive

and unfair practices , and that Iowa has alleged an unfair practice.

(Doc. 150 at 70-71.)

The Iowa Consumer Fraud Act ,

unlawful

for

practice."

a

person

to

"act,

Iowa Code § 714 .1 6,

use

Iowa Code§ 714 .1 6(2) (a).

or

employ []"

an

makes it

"unfair

For the same reasons stated

above, Defendants have not demonstrated that the court should read

"unfair" any more narrowly than under the FTC Act .

As a result ,

Defendants ' motion to dismiss the Iowa consumer protection claim

wil l be denied.

III . CONCLUSION

For the reasons stated,

IT IS THEREFORE ORDERED that Defendants ' motions to dismiss

(Docs. 94 , 99) are DENIED.

Isl

Thomas D. Schroeder

United States District Judge

January 12, 2024

88

Case 1:22-cv-00828-TDS-JEP Document 160 Filed 01/12/24 Page 88 of 88

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.